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Abstract
Lung cancer is the leading cause of cancer related death. Radiation therapy is a prominent
treatment method but leads to adverse consequences. Radiation-Induced Lung Injury (RILI)
is the primary adverse consequence that limits further radiation therapy and develops in 537% of the treated patients. RILI proceeds in two distinct phases: a) early and reversible
Radiation Pneumonitis (RP), and b) late and irreversible radiation fibrosis. Clinically, Dose
Volume Histogram (DVH) parameters derived from radiation therapy planning stage are
used to determine outcome and severity of RP but have been demonstrated to possess a very
low predictive power. Computed Tomography (CT) is the most commonly used modality for
the imaging of RP, but often only detects very late RP that leaves little room for intervention
to abort the progress to irreversible radiation fibrosis. Early detection of RP using imaging
may allow for interventional treatment and management of the disease and the associated
symptoms in a better manner. Improvement in Dynamic Nuclear Polarization (DNP)
technology has led to advancement of hyperpolarized 13-Carbon-Magnetic Resonance
Imaging (13C-MRI). In this thesis, we present the investigation of early detection of RP with
13

13

C-MRI in an animal model with the use of hyperpolarized

C-pyruvate. A pilot study

demonstrated the proof of concept along with a qualitative histological confirmation.

13

C-

MRI data and histology data were collected 2 weeks post irradiation of whole thorax in
rodents. In the subsequent study, regional and longitudinal

13

C-MRI and quantitative

histology data were analyzed to demonstrate the early organ-wide response of RP. These data
were collected at day 5, 10, 15 and 25 post conformal irradiation of the right rodent lung.
Finally, we demonstrate a novel approach to map pH using hyperpolarized

13

C-bicarbonate

with the use of spiral-Iterative Decomposition of water and fat with Echo Asymmetry and
Least squares estimation (IDEAL) pulse sequence. Validation of this approach by
comparison to Chemical Shift Imaging (CSI) pH measurement and standard pH measurement
with the aid of phantoms along with hyperpolarized

13

C-bicarbonate is presented. pH

mapping may play a role in the staging and therapeutic intervention of cancer.
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Chapter 1: Introduction
This chapter provides the introduction and motivation for the work presented in this thesis. A
review of healthy lung physiology, Radiation-Induced Lung Injury and radiopathology of the
irradiated lung is provided in sections 1.2, 1.3 and 1.4. Section 1.7 provides an introductory
review of basic physics of Magnetic Resonance Imaging (MRI). Section 1.8 describes the
hyperpolarization process and biological context for the 13C-susbstrates used in the thesis. To
put the research work within context, clinical and functional imaging methods for RadiationInduced Lung Injury are introduced in Sections 1.5 and 1.6. Organization of the thesis is
provided towards the end of this chapter (section 1.9).

1.1 Overview and Motivation
Recent developments in the hyperpolarization process have led to the imaging of Carbon-13
(13C)-labelled substrates and their corresponding downstream metabolites in vivo in real time
(1), enabling the study of specific enzyme-catalyzed reactions coupled to metabolism.
Changes in metabolism precede anatomical and functional changes and can help identify
diseases at an earlier time point than conventional imaging.
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C-MRI has been moderately

successful at detection of abnormal metabolism in cancer at a pre-clinical level and is now
moving towards clinical application, most recently in the form of a phase I clinical trial for
prostate cancer. (2) Lung cancer is responsible for the most cancer related deaths, with
radiation therapy as one of the prominent methods of treatment. Up to 37% of the lung
cancer patients treated with radiation therapy develop Radiation-Induced Lung Injury (RILI).
(3) In this thesis, 13C-MRI is used to image metabolism in real time in a rat model of RILI.
The aim of the work was to detect regional metabolic changes in RILI prior to any functional
or anatomical changes. Additional work towards pH mapping with
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C-MRI was also

performed with application towards diseases with abnormal regional pH such as cancer.

2

1.2 Healthy Lung Physiology
The primary function of the lung is to facilitate gas exchange, specifically absorption of
oxygen and elimination of carbon dioxide. The lung enables this process using a large
surface area for the contact of air and blood separated by a very thin tissue boundary. (4) The
structure of the lung begins with the largest airway called the trachea, which progressively
branches twenty-three times into narrower airways until the alveolar level is reached. (5)
Alveoli are tiny air sacs consisting of a very thin tissue boundary (or septum) that is the site
of gas exchange. Driven primarily by diffusion, gas exchange takes place as the inhaled
oxygen is able to diffuse into the capillaries from the alveoli and carbon dioxide is able to
diffuse from capillaries to the alveoli. There are on average 480 million alveoli in the human
lung (6) and the total air exchange surface area is approximated to 130 m2. (4) The interested
reader is referred to “Respiratory physiology: The Essentials” by John B. West (7) for
comprehensive details on lung function, ventilation and gas exchange.

1.3 Lung Function Tests
A variety of respiratory diseases can lead to the impairment of lung function. Pulmonary
Function Tests (PFT) are used to evaluate global function of the diseased lung. The most
common PFT is spirometry, which measures airflow as a function of time during both the
inspiration phase and the expiration phase of a breathing cycle and is widely considered the
gold standard for measuring lung function. (8) Forced Expiration Volume in One Second
(FEV1), the maximum volume of air expired during forced expiration in one second is used
to evaluate severity of the disease. In addition, plethysmography is widely used to measure
static lung volumes. Spirometry and plethysmography are quick and inexpensive but do not
provide any information about gas exchange. Measurement of Diffusing Capacity of Carbon
Monoxide (DLCO) provides insight into diffusion of gases across the alveolar membrane by
quantifying the alveolar volume and the concentration of carbon monoxide in exhaled gas
following inhalation of a known quantity of carbon monoxide gas. (9) Measurement of
Partial Pressure of Oxygen in Arterial Blood (paO2) is used to identify the global level of
hypoxia in the body. A paO2 measurement of less than 60 mmHg is considered as clinical
hypoxia. (10) All these tests measure global lung function and overall health of the
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respiratory system, but lack regional information. Spatial localization of the underlying
disease may provide a better insight into the disease pathology. Improved sensitivity may
also aid in earlier detection of the underlying disease.

1.4 Radiation Therapy of Lung Cancer
1.4.1 Lung Cancer
Lung cancer is responsible for the highest number of cancer deaths in the US population (11)
and in the global population. (12) Smoking has been established as one of the largest risk
factors globally and is responsible for lung cancer in 80% and 50% of males and females
respectively. (13) There is no known screening test for lung cancer. The diagnosis usually
comes after presentation of clinical symptoms such as tiredness, lack of energy, shortness of
breath, coughing, lack of appetite, hemoptysis, chest pain and dyspnea. (14) The prognosis
for lung cancer is very poor with global 5-year survival for lung cancer patients ranging
between 6-14% for men and 7-18% for women. (15) Lung cancer can be broadly divided into
two major categories with about 85 – 90% of the cases categorized as Non-Small Cell Lung
Carcinoma (NSCLC) and 10 – 15% of the cases as Small Cell Lung Carcinoma (SCLC). (16)
Internationally accepted staging of lung cancer is based primarily on three categories: Tprimary tumour, N-regional lymph nodes, and, M-distant metastasis, known as the (TNM)
classification system. T ranges from one to four based on the size and location of the primary
tumour within the thorax. N is assigned a value from zero to three based on the metastasis
and location of regional lymph nodes within the thorax. M is assigned a one if a distant
metastasis is present, zero otherwise. (17) Following the TNM classification of the lung
cancer, it is grouped into stages ranging from stage I to stage IV where each overall stage has
similar treatment options and survival. For example, stage II could be one of T1N1M0,
T2N1M0 and T3N0M0.

1.4.2 Treatment of Lung Cancer
Surgical resection, radiation therapy and chemotherapy are the three most common treatment
options for lung cancer patients. Radiation therapy is one of the most prominent methods
used for treatment of lung cancer for curative as well as palliative care. It is used in 49.3% of
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the NSCLC patient population and 47% of the SCLC patient population. (18) Standard
treatment for stages I and II lung cancers is a surgical operation. (19) Adjuvant therapy may
be offered to the patient post resection in the form of radiation therapy or chemotherapy. (20,
21) Patients unfit for surgery due to poor PFT are treated with radiation therapy. Curative
therapy for stage III lung cancer is provided with chemotherapy in combination with
radiation therapy or surgery. Treatment for Stage IV cancer patients is a combination of
chemotherapy and palliative radiation therapy. (19, 22)

1.4.3 Radiation-Induced Lung Injury (RILI)
Radiation therapy for the treatment of lung cancer is used with a curative intent, but can lead
to adverse consequences. The therapeutic radiation beam is not only damaging to the lung
cancer but often the healthy tissue around it as well. As the lung is an extremely
radiosensitive organ, (23) irradiation of the healthy tissue leads to unintended consequences
known as RILI. This leads to a significant degradation in quality of life of the patient due to
symptoms such as dyspnea, cough and fever that accompany decline in lung function. (3) In
addition, onset of RILI is the primary criterion that limits the allowable therapeutic dose.
RILI occurs in up to 37% of lung cancer patients treated with radiation therapy and the
incidence of moderate to severe injury ranges from 10-20%. (24) The three-year survival rate
for subjects with severe RILI is a dismal 0%. (25)
RILI occurs in two distinct stages, the Radiation Pneumonitis (RP) phase and the radiation
fibrosis phase. A schematic of pathological events post radiation therapy leading to RP and
fibrosis is shown in Figure 1-1. RP is the initial acute phase and presents with symptoms of
shortness of breath, cough and mild fever that onset 1 – 6 months after the beginning of
radiation therapy. (26) RP is marked by inflammation and macrophage accumulation and
proliferation, leading to capillary obstruction and septal thickening. (3, 27) If RP is not
treated in time with steroids, (26) the persistence of Reactive Oxygen Species (ROS),
hypoxia, proliferation of macrophages and cytokines transform RP in to radiation fibrosis.
The chronic phase of radiation fibrosis is an irreversible process and typically occurs months
to years after the onset of radiation therapy and is marked by progressive chronic dyspnea.
(26)
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1.4.4 Radiopathology of Irradiated Lung Tissue
Ionizing radiation to the lung inflicts injury primarily to type II pneumocytes and vascular
endothelial cells leading to leakage of protein rich plasma into alveolar space resulting in
edema and infiltration by inflammatory macrophages. Histological evidence of edema and
inflammation during RP is shown in Figure 1-2. These changes cause impairment of gas
exchange and reduction in lung compliance. (28-30) At a cellular level, tissue hypoxia is an
important contributing factor in mediation of the inflammatory process and the onset of RP.
(31) Clinically, paO2 has been used as an indicator of hypoxia with a measurement of below
60 mmHg deemed as clinical hypoxia (10). Persistence of hypoxia has been reported post
radiation therapy (32, 33) and recent studies suggest that it may exacerbate lung injury
further. (26) Immunohistochemical analysis in animal models of RILI reveals underlying
changes in resident alveolar macrophages, inflammatory cytokines, type II pneumocytes,
endothelial cells and fibroblasts. (34, 35) During RP, an inflammatory reaction takes place in
response to the radiation damage and as a result leukocytes are recruited from outside the
radiation field. (36) Fibroblasts are the first to respond and release cytokines along with
chemotactic factors. Circulating monocytes follow to the site of the injury and differentiate
into macrophages. (37) Macrophages are a source of ROS and the inflammatory cytokines.
The growth factors affect the endothelial cells and may lead to angiogenesis. In addition,
mast cells may also be present and lead to synthesis and storage of histamine and cytokines.
(35) Persistence of hypoxia and cytokines leads to chronic oxidative stress and tissue
remodelling which instead of restoring the healthy lung tissue results in radiation fibrosis.
The onset of hypoxia alters the process of glycolysis in a cell by switching from
predominantly aerobic respiration to anaerobic respiration. As the oxygen availability
diminishes, anaerobic respiration starts to play a bigger role in the production of energy
molecule Adenosine Triphosphate (ATP) in the cell. This phenomenon is known as the
Pasteur effect and leads to a higher production of lactate inside the cell. (38) Further evidence
on Hypoxia Inducible Factor-1 (HIF-1) that presents with onset of hypoxia suggests that it
regulates glycolysis for additional lactate production to ensure cell survival. (39)

6

Figure 1-1: Radiation therapy leads to tissue damage that induces an inflammatory reaction
and macrophage activation and accumulation. Hypoxia mediates these processes and further
leads to cytokine and ROS production during Radiation Pneumonitis. These progressions
cause additional tissue damage to type II pneumocytes and endothelial cells. If hypoxia and
cytokines persist, over time they lead to chronic oxidative stress and tissue remodelling that
results in irreversible lung fibrosis. Adapted from reference (26).
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Figure 1-2: Haematoxylin and eosin stained sections of healthy lung (left) and irradiated
lung (right) from C57BL/6J mice post 12.5 Gy dose at 100× magnification (top) and 180×
magnification (bottom) showing edema and inflammation during RP (2 weeks postirradiation). Arrow 1 shows alveolar wall thickening, arrow 2 shows interstitial edema and
arrow 3 shows peribronchial inflammation. Adapted from reference (40).

1.5 Clinical Diagnosis of Radiation-Induced Lung Injury
1.5.1 Epidemiology and Risk Factors
As described earlier, RILI develops in up to 37% of lung cancer patients post treatment with
radiation therapy and moderate to severe injury develops in 10-20% of lung cancer patients.
(24) Multiple risk factors for RILI have been identified from the existing data in the
literature. Some of these include pulmonary dysfunction (paO2 < 80 mmHg), poor PFT
outcome, concurrent chemotherapy and radiation therapy, primary tumour located in lowerlobe of lung, large treatment volume, high dose rate, high dose and elevated levels of
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Transforming Growth Factor Beta One (TGFβ1). (25, 41-45) These risk factors can be
categorized as either treatment-specific or patient-specific as shown in Table 1-1.

•
•
•

treatment-specific
large treatment volume
high dose and dose rate
concurrent chemoradiation with
chemotherapy drugs such as:
cisplatin, paclitaxel, docetaxel and
mitomycin C

•
•
•
•
•

patient-specific
poor performance status
smoking history and pulmonary
dysfunction (paO2 < 80)
old age, > 60 years
primary tumour located in lower
lobe
elevation of TGFβ1 post treatment

Table 1-1: Risk factors for development of Radiation Pneumonitis post radiation therapy.
Adapted from reference (46)
Despite the identification of risk factors, clear predictive relationships between risk factors
and RP have not been established. (47) Although widespread use of 3D-Computed
Tomography (CT) has led to improvements in dose planning accuracy whereby high dose is
delivered to the target tissue (e.g. tumour) and minimal dose is delivered to the surrounding
healthy tissue, RILI is still not predictable. Dose Volume Histogram (DVH) parameters can
be helpful and conveniently generated from the 3D-CT plans. Generation of DVH parameters
and their implication to RILI are discussed further in the next section.

1.5.2 Dose Volume Histogram Parameters
DVH parameters provide a cumulative dose-volume relationship for single or paired organs
in a graphic and mathematical plot. The 3D dose plan from CT is converted to a 2D format
that is easier to visualize for dose to the tumour and the critical structures around it. This
allows for easier identification of dose threshold to the volume of tumour and the volume of
healthy tissue. (46) The major drawback of DVH parameters is the lack of 3D spatial volume
and the assumption that all spatial volumes are equal in function. Figure 1-3 shows a
representative DVH for treatment of lung tumour with dose-volume plotted as a function of
total dose for various tissues as well as the planning target volume i.e. tumour and
surrounding tissue.
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1.5.3 Signs, Symptoms and Radiographic Findings
Radiation Pneumonitis can manifest as a symptomatic or as an asymptomatic injury.
Symptoms of the injury can start as soon as 1 month and as late as 6 months post radiation
therapy, but often appear at 2-3 months after the treatment. Dyspnea is the most prominent
symptom of RP and can progress into severe respiratory illness. Several other symptoms such
as hemoptysis, cough, fever and chest pain can also co-exist. (46) Patients with asymptomatic
of RP are often revealed by radiographic findings on plane film chest X-ray at the very late
stage of RP. Changes appear as increased ground glass opacity and lack of clear
demarcations of normal pulmonary structure following radiation therapy. (52) These changes
can range from minimal i.e. slight indistinctness of pulmonary vasculature to complete
consolidation of the irradiated area. (53) Computed tomography (CT) indications of very late
RP are often observed post radiation therapy. CT evidence for RILI is described as: i)
increase in density uniformly across the irradiated volume ii) patchy consolidation not
conforming to the irradiated volume iii) discrete, non-uniform consolidation across the
irradiated volume, and iv) solid consolidation across the irradiated volume and associated
bronchi. (54) Figure 1-4 demonstrates two cases of RILI-CT appearance post radiation
therapy treatment that are distinctly different in their appearance and region of occurrence.
CT is considered more sensitive than plane film X-ray for early detection of RILI. (54-56)
Detection of late RP by X-ray and CT is of little help, as the late detection offers no
opportunity to modify the radiation therapy treatment plan.

Figure 1-4: Left image for a) and b) show axial CT treatment planning image with contours
conforming to radiation therapy isocenter. Corresponding right image in a) was taken 5
months after radiation therapy and shows appearance of late RP as irregularly shaped
consolidation, non-conformal to dose deposition curves. Right image in b) was taken 6
months post radiation therapy and shows appearance of RP as solid homogeneous
consolidation in the irradiated area. Figure adapted from (57).
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1.6 Functional Imaging of Radiation-Induced Lung Injury
Imaging modalities such as Single Photon Emission Computed Tomography (SPECT),
Positron Emission Tomography (PET) and MRI have been used to perform imaging of RILI.
Measures of ventilation, perfusion, relaxation times and apparent diffusion coefficients by
these modalities can provide a sensitive measure to assess lung anatomy and function.

1.6.1 Nuclear Medicine Imaging Methods
Functional imaging with SPECT can provide ventilation and perfusion maps of the lung post
injection of Technetium-99m. (58, 59) Studies have demonstrated a dose-dependent
reduction in perfusion and ventilation at 3-4 months post radiation therapy. (60, 61)
However, correlations between these metrics and whole lung function assessed by PFT are
low and additional work is required to assess regional injury. (62) Additionally, SPECT
imaging is limited in resolution, lacks specificity and provides ~3 mSv of extra whole body
radiation dose to the patient. (63) PET imaging with Fluorodeoxyglucose (18F-FDG) has been
performed in lung cancer patients post radiation therapy. The technique is heavily dependent
on tissue uptake of 18F-FDG and is susceptible to a high false positive rate. (64) High uptake
of

18

F-FDG is associated with inflammation and tumour growth but no clear separation of

cancer and RP has been demonstrated. (65) The tumour response is highly correlated to the
detection of inflammatory change by PET. (66) As with SPECT, PET also provides
additional radiation dose to the patient and is limited in resolution.

1.6.2 Magnetic Resonance Imaging Methods
MRI uses non-ionizing Radiofrequency (RF) pulses to obtain multiplanar images that are rich
in soft-tissue contrast. Functional MRI has been used to assess lung injury post radiation
therapy using a variety of methods. Perfusion imaging using Gadolinium-99mTcDiethylenetriaminepentaacetic acid (Gd-DTPA) has demonstrated consistent contrast
enhancement in irradiated dog thorax compared to an unirradiated dog thorax. (67)
Significant increases in relaxation times (𝑇! and 𝑇! ) have also been shown in rat thorax post
irradiation. (68) Hyperpolarized gas imaging (3He) with MRI has demonstrated changes in
apparent diffusion coefficients in rodent lungs post radiation injury. (69) This technique has
been applied in a clinical setting and correlation between severity of radiation injury and
percent-ventilated volume has been quantified. (70) While functional MRI methods
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demonstrate an improvement over the nuclear medicine imaging methods, they are still based
on morphological and functional changes that often occur during the late phase of the injury.
As metabolic changes precede morphological and functional changes, quantification of
metabolic signature may help capture early onset of the disease. As such, metabolic imaging
of early RP with hyperpolarized
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C-pyruvate may lead to early diagnosis of the disease

using MRI. A review of basic MRI concepts that are applicable to this thesis is provided in
the next section.

1.7 Nuclear Magnetic Resonance
The source of detectable signal in Nuclear Magnetic Resonance (NMR) is the precession of
an ensemble average of nuclear magnetic moments in the presence of an applied static
magnetic field. Interaction of this ensemble, or magnetization, with time-dependent
secondary magnetic fields provides an array of information about their spatial position and
local environment. The origin of the magnetization and its interaction with an external
magnetic field can be described theoretically using either or both of a quantum mechanical
approach or a classical approach. The interested reader is referred to (71, 72) for more
details. In this section, introductory background material is provided on the origin of nuclear
magnetization, behaviour in the presence of external magnetic fields, polarization and
chemical shift as a theoretical basis for the thesis work described. The basics of the MRI
pulse sequence for Chemical Shift Imaging (CSI), gradient echo imaging and finally, the
Dixon approach, central to the methods used in this thesis, are also described.

1.7.1 Nuclear Magnetic Moment
The atomic nucleus is composed of neutrons and/or protons. NMR is derived from nuclei
consisting an odd number of neutrons and/or protons. These unpaired neutrons and/or
protons confer a property to the nucleus know as spin (I). Spin causes the nucleus to behave
as a spinning charge enabling the nucleus to acquire a spin angular momentum (J). The
resulting magnetic moment is given by:
𝜇 =   𝛾𝐽 =   𝛾ħ𝐼,

[1]
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where 𝛾 is the gyromagnetic ratio of the nucleus under consideration, J is the spin angular
momentum, ħ is the reduced Planck’s constant, and I is the integer half-spin. Gyromagnetic
ratios of the two nuclei discussed in this thesis are given in Table 1-2.
Nucleus
1

H

13

C

𝛾 [MHz rad -1 T-1]
267.519
67.261

Table 1-2: Gyromagnetic ratios for Spin ½ Nuclei described in this thesis.

1.7.2 Magnetic Moment in the Presence of a Magnetic Field
In the presence of a uniform external static magnetic field, 𝐵! , the magnetic moment
experiences a torque. This torque is described by the following equation:
𝜏 =    𝜇  ×  𝐵! .

[2]

The principle of conservation of angular momentum requires that this torque be equivalent to
the time derivative of the angular momentum, leading to the following equation of motion:
𝑑
𝐽 =    𝜇  ×  𝐵! .
𝑑𝑡

[3]

Incorporating equation [1] into equation [3] yields:
𝑑
𝜇 =    𝜇  ×  γ𝐵! .
𝑑𝑡

[4]

The above differential equation has a well known solution and is given by:
𝜇 =    𝜇! 𝑒 !!"# ,

[5]

where 𝜔 is the Larmor frequency and is represented by the equation of motion that describes
precession, such that:
𝜔 =    −𝛾𝐵! ,

[6]
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The negative sign implies a clockwise direction of rotation when looking into the head of the
vector 𝐵! . 𝜔 can be readily converted to frequency in Hz by the following expression:
[7]

𝜔 = 2𝜋𝑓.
Therefore, the expression for Larmor frequency in Hz is as following:
𝑓 =    −

𝛾
𝐵 .
2𝜋 !

[8]

1.7.3 Magnetization and Polarization
In the presence of an external magnetic field, nuclei that possess spin angular momentum
tend to align with the magnetic field. The potential energy of a magnetic moment in the
presence of an external magnetic field is given by:
[9]

𝐸 =    −𝜇 ∙ 𝐵! .

The nuclei in Table 1-2 can exist in either I = + ½ spin state or I = − ½ spin state. The spin
state of + ½ corresponds to alignment with the external magnetic field and is referred to as
spin up, whereas the spin state of − ½ corresponds to alignment against the external magnetic
field and is referred to as spin down. Net magnetization arises from a vector sum of spins
aligned with the external magnetic field in a unit volume. Following equation [9], the spin
states are separated by a net amount of energy given by:
Δ𝐸 =   𝛾ħ𝐵! .

[10]

Alignment of spins is approximated by the Boltzmann distribution. The ratio of nuclei with
spin up state to nuclei with spin down state at a given temperature T is given by:
𝑁↓
= 𝑒 (!∆!
𝑁↑

!")

,

[11]

where 𝑁↑ is the number of spins aligned with the magnetic field and 𝑁↓ is the number of
spins aligned against the magnetic field. This phenomenon of spin alignment is depicted in
Figure 1-5 that shows an aggregate of spins placed in an external magnetic field 𝐵! . The
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excess of I = + ½ spins aligned with the external magnetic field compared to I = − ½ gives
rise to polarization, which is defined as:
𝑃 =   

𝑁↑ −    𝑁↓
.
𝑁↑ +    𝑁↓

[12]

Rearrangement of equations [10], [11], [12] provides the following expression for thermal
polarization:
𝑒 ∆!
𝑃 =    ∆!
𝑒

!"

−    𝑒 !∆!
!" +    𝑒 !∆!

!"
!!

= 𝑡𝑎𝑛ℎ

∆𝐸
ħ𝛾𝐵!
= 𝑡𝑎𝑛ℎ
.
𝑘𝑇
2𝑘𝑇

[13]

Typically 2𝑘𝑇 is a much bigger quantity than ħ𝛾𝐵! , simplifying the expression for
polarization in equation [13] to:
𝑃   ≅   

ħ𝛾𝐵!
.
2𝑘𝑇

[14]

Figure 1-5: An aggregate of spins placed in an external magnetic field.
Magnetization can be expressed in terms of polarization in the following way:
𝑀 = 𝑁 ∙ 𝜇   ∙ 𝑃,

[15]
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where N is the number of magnetic dipole moments per unit volume. Combining equations
[1], [14] and [15] leads to the following expression for the net magnetization in the presence
of an external magnetic field 𝐵! :
𝑀! = 𝑁

ħ𝛾
2

ħ𝛾𝐵!
𝑁ħ! 𝛾 ! 𝐵!
=   
,
2𝑘𝑇
4𝑘𝑇

[16]

where 𝑀! refers to equilibrium magnetization.

1.7.4 Chemical Shift
The local magnetic field experienced by the nuclear spin is dictated by the local electron
distribution. This leads to a phenomenon called chemical shift whereby spins in different
chemical environments resonate at slightly different Larmor frequencies. The phenomenon of
in vivo chemical shift is depicted in Figure 1-6, where the
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C-nuclei exhibit a different

resonant frequency dependent upon the chemical environment of the host molecule.
The fundamental reason for the difference in chemical shifts is the interaction of the external
magnetic field with the variable local electron cloud distribution in the environment where
the nuclei of interest reside. For example, protons in water molecules resonate at a different
frequency in a tissue environment that primarily consists of muscle compared to a tissue
environment that is primarily fat. The electron cloud arranges itself to oppose the external
magnetic field, such that the effective magnetic field, 𝐵!! , for the local tissue environment is
given by:
𝐵!! =    𝐵! 1 −   𝜎 ,

[17]

where 𝜎 is the shielding constant that depends on local tissue environment. Chemical shift is
usually expressed in parts per million (ppm) of the applied magnetic field, by combining
equation [17] with the Larmor equation as:
𝛿 =   

𝜔! −    𝜔!
   ∙    10! ,
𝜔!

[18]
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where 𝜔! is the Larmor frequency associated with the local tissue environment and 𝜔! is the
predetermined reference frequency for a native frequency of 𝜔! . It should be noted that
frequency expressed in 𝛿 is independent of the external magnetic field.

pyruvate

pyruvatehydrate
lactate

alanine

bicarbonate
190

185

180 175 170 165
Frequency (ppm)

160

Figure 1-6: Metabolite products of 13C-pyruvate in vivo resonate at different frequencies as
the 13C-nuclei experience different chemical shifts due to different chemical environments.

1.7.5 Radiofrequency Pulse
RF pulses manipulate the magnetization of a sample to generate the signal in NMR. RF coils
are the electric antennae that produce these pulses. Applying a transverse RF pulse to a spin
system results in an additional time-varying magnetic field called 𝐵! that exerts itself in a
direction perpendicular to the main magnetic field 𝐵! . This additional magnetic field is a
rotating vector with a frequency equal to the Larmor frequency of the nuclei under
consideration. As 𝐵! is a rotating vector, it is convenient to transform the reference
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coordinates from a laboratory frame to the rotating frame about z-axis (direction of 𝐵! ) with
frequency of 𝜔! . The effective magnetic field 𝐵!"" can then be described as:
𝐵!"" =    𝐵! 𝚤 +    𝐵! −   

𝜔!
𝑘 =    𝐵! 𝚤.
𝛾

[19]

𝐵! is applied along the x-direction and the result is tipping of the net magnetization to ydirection of the rotating frame of reference. The purpose of 𝐵! is to tip, or nutate, the net
magnetization by a flip angle 𝛼, represented as:
!

𝛼 =   𝛾

𝐵! 𝑡    ∙ 𝑑𝑡,

[20]

!

where 𝑡 denotes the duration of 𝐵! . Following equation [4], once the aggregate of spins is
perturbed from the direction of the static magnetic field of 𝐵! , the macroscopic behaviour
can be represented by the following equation:
𝑑
𝑀 =    𝑀  ×  γ𝐵!"" =    𝑀  ×  γ𝐵! 𝚤.
𝑑𝑡

[21]

If a flip angle of 𝛼 =   𝜋/2 is used for 𝐵! , the net magnetization completely aligns in the ydirection. A static frame of reference, rotating frame of reference and the process of tipping
magnetization, referred to as the excitation pulse are shown in Figure 1-7.
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Figure 1-7: The lab frame (x, y, z) and the rotating frame (x’, y’, z’). After the
transformation, application of a RF pulse (𝜶 =   𝝅/𝟐) in the x’-axis will lead to tipping of net
magnetization in the y’-axis.
After the excitation RF pulse with a flip angle of 𝛼, the net magnetization slowly returns to
equilibrium i.e. re-aligns with 𝐵! . This process of relaxation is called longitudinal relaxation
or spin-lattice relaxation.

1.7.6 Longitudinal and Transverse Relaxation
Spin-lattice relaxation occurs as the excited magnetic dipoles return to equilibrium by
interacting with the surrounding lattice. Spin-lattice relaxation is described using an
exponential time decay constant 𝑇! , called the longitudinal or the spin-lattice relaxation time.
The time dependence of the longitudinal component of magnetization, 𝑀! in the presence of
longitudinal relaxation is expressed by the following differential equation:
𝑑𝑀!
𝑀! −    𝑀!
=    −  
,
𝑑𝑡
𝑇!

[22]

where 𝑀! is the equilibrium magnetization and 𝑇! is the longitudinal relaxation time constant.
The general solution for equation [22] is:
𝑀! 𝑡 = 𝑀 0 𝑒 !!

!!

+    𝑀!   1 −    𝑒 !!

!!

,

[23]

where 𝑀 0 is the longitudinal magnetization at zero time. For an excitation RF pulse of
𝛼 =    𝜋 2, 𝑀 0 = 0 and the second component of equation [23], 𝑀!   1 −    𝑒 !!

!!

dictates
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the re-growth of magnetization to thermal equilibrium such that the magnetization re-grows
to ~63% of the thermal equilibrium in one 𝑇! .
Relaxation transverse to 𝐵! or spin-spin relaxation occurs due to local alteration in magnetic
fields that the spins experience relative to neighbouring spins. Slight variance in the
environment of the spins leads to different local magnetic fields. The dipolar interaction
between these spins causes a dephasing of the transverse magnetization and a broadening of
the resonant frequency. This relaxation is described by an exponential time decay constant
𝑇! , called the transverse relaxation or the spin-spin relaxation time constant. This
phenomenon is described by the following differential equation:
𝑑𝑀!"
𝑀!"
=    −
,
𝑑𝑡
𝑇!

[24]

where 𝑀!" is the magnetization in transverse plane. The general solution for equation [24]
results in:
𝑀!" 𝑡 = 𝑀 0 𝑒 !!

!!

,

[25]

where 𝑀 0 is the transverse magnetization immediately following an excitation RF pulse.
Another transverse relaxation time constant called the apparent transverse relaxation time,
𝑇!∗ , is shorter than 𝑇! , due to additional components that cause dephasing of the transverse
magnetization. Some of these components include: static 𝐵! inhomogeneities, magnetic
susceptibility differences, chemical exchange, diffusion and chemical shift. Exponential time
decay with transverse relaxation time constant 𝑇!∗ results in a Free Induction Decay (FID).
The Fourier transform of a FID is a Lorenzian shape where the width of the peak is
dependent on the 𝑇!∗ of the FID. This is shown in Figure 1-8.
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Figure 1-8: Top left shows a FID with an apparent transverse relaxation time constant, 𝑻∗𝟐 .
Top right shows a Lorentzian peak, which is the Fourier transform of the FID. Full-width at
Half Maximum (FWHM) of the Lorentzian peak is related to 𝑻∗𝟐 such that a longer 𝑻∗𝟐 results
in a lower FWHM for the Lorentzian peak.

1.7.7 MR Signal and RF Coils
The Bloch equation describes the time evolution of magnetization in the rotating frame of
reference, in the presence of an external static magnetic field (𝐵! ), a time varying magnetic
field (𝐵! ) and associated longitudinal and transverse relaxation. The magnetization varies
with time as:
𝑀! 𝑥 +    𝑀! 𝑦
𝑑𝑀
𝑀! −    𝑀! 𝑧
=   𝛾𝑀  ×  𝐵 −   
−   
,
∗
𝑑𝑡
𝑇!
𝑇!

[26]

where 𝑇! and 𝑇!∗ are the longitudinal and apparent transverse relaxation time constants
respectively.
A RF coil is used to transmit the time-varying magnetic field and/or receive the voltage
generated by the sample. Based on Faraday’s law of electromagnetic induction, the time
varying magnetization generates a corresponding electromotive force or voltage in the RF
coil. Since 𝐵! is produced by the RF coil; based on the principle of reciprocity, the sensitivity
of a coil can be measured by the transverse field that the coil produces upon application of 𝐵!
per unit amount of current produced by the coil. The induced voltage can be expressed as:
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𝑑
𝑉 𝑡 =   
𝑑𝑡

!

𝑑𝑉   ∙    𝐵! 𝑟

!"

   ∙    𝑀!" 𝑟, 𝑡   ,

[27]

!!

where 𝑉! represents the volume of the sample over which the integral is calculated. The final
voltage obtained contains the Larmor frequency of all the chemical species present in the
sample and varies as a function of time as it is modulated by the relaxation mechanisms
previously discussed. The final signal obtained is the FID, and is represented as:
!

𝑆 𝑡 = 𝐴𝜔!

𝑑𝑉   ∙   𝐵! 𝑟

!"

   ∙    𝑀!",! 𝑟    ∙ 𝑒 !!

!!∗

   ∙    𝑒 !!∆!" ,

[28]

!!

where A is a constant that depends on coil filling, coil geometry, gain and frequency
response of the receiver. ∆𝜔 is the range of Larmor frequencies detected by the RF coil and
depends on the bandwidth of the RF receive coil and the magnetic gradients applied for
spatial encoding.
A RF coil primarily consists of electrical resonant circuits and is used to transmit the timevarying magnetic field 𝐵! and/or receive the voltage 𝑉, generated by the spin system. The
geometry of RF coils is carefully chosen to maximize the Signal-to-Noise-Ratio (SNR) and
produce good quality images. The frequency of the electrical resonant circuit of a coil is
tuned very closely to the Larmor frequency of interest. This enables the coil to provide
efficient transmission of 𝐵! and sensitive reception of 𝑉 from the spin system. The resonance
behaviour of the coil can be approximated by a combination of its inductance and
capacitance in the following manner:
𝜔 =   

1
𝐿𝐶

  ,

[29]

where L is the total inductance of the RF coil and C is the total capacitance of the RF coil
respectively. A volumetric (distributed capacitance) design of coils generally known as a
birdcage is regarded as the best for 𝐵! homogeneity at clinical magnetic field strengths (<
3T). Birdcage coils are versatile and are often used for both transmit and receive operation.
The distance between the sample and coil is an important consideration for sensitivity of the
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coil. As shown in equation [28], the MRI signal is dependent on the integral over the volume
present in the RF coil. In general, the coil sensitivity is inversely proportional to the distance
between the coil elements and the sample. This property enables surface coils to attain a
higher sensitivity in general as they can be placed fairly close to the sample. The shortcoming
of surface coils is the non-uniform transmission of 𝐵! . Advantages of a birdcage design
(uniform transmission of 𝐵! ) and a surface coil (higher sensitivity) can be combined to form
a Transmit-Only/Receive-Only (TORO) system that offers the best SNR. In this system, the
larger birdcage coil is used to provide very uniform 𝐵! field only and a highly sensitive
surface coil is used for reception of signal only. As a part of the research for this thesis, a
TORO system was developed for in vivo

13

C-MRI. Details on design, construction and

operation can be found in the Appendix A-1. It is the highly sensitive TORO system that
enabled spatial disease characterization in Chapter 3.

1.7.8 Spatial Localization of Spins
The signal received from the spins must be spatially localized in order to form an image.
Spatial localization of the spins is performed by the use of gradient magnetic fields in
addition to 𝐵! . Gradients can be applied in all three directions such that the net magnetic
field is represented as:
𝐵 𝑥, 𝑦, 𝑧 = 𝐵! 𝑘 +    𝐺! 𝑥 +    𝐺! 𝑦 +    𝐺! 𝑧   𝑘,
where 𝐺! =   

!!!

  , 𝐺! =   
!"

!!!
!"

  𝑎𝑛𝑑  𝐺! =   

!!!
!"

[30]

   . The combined field points in the z-direction

with variations in x, y, and z direction for spatial localization. The application of gradients
leads to additional accumulation of phase, which is typically represented in the following
way:
𝑘 =   

𝛾
2𝜋

!

𝑑𝑡!    ∙    𝐺 𝑡 ! ,

[31]

!

where 𝐺 𝑡 ! is the time varying gradient magnetic field that is turned on for a time 𝑡.
Application of a gradient magnetic field and resulting accumulation of phase is represented
by the position of a vector in k-space, 𝑘. k-space is a convenient method to represent the
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acquired MRI data and contains spatial frequency components obtained by Fourier transform
of the effective spin density.
A slice select gradient is used to spatially localize a 2D slab of the sample. The slice select
gradient is turned on simultaneously along with a RF pulse. An axial slice is excited with the
thickness ∆𝑧, which is defined by:
𝐵𝑊!"
∆𝑧 =    𝛾
,
𝐺
2𝜋 !

[32]

where 𝐵𝑊!" is the bandwidth of the corresponding RF pulse and 𝐺! is the strength of the
slice-select gradient (conventionally assumed to be in the direction of the magnet bore).
Phase is accumulated during the time the slice-select gradient is turned on, and an additional
gradient is applied in the opposite direction after slice-select gradient to rewind the
accumulated phase. This is demonstrated by 𝐺! in Figure 1-9.
Further spatial localization in the 2D slab can be attained using frequency- and phase-encode
gradients that can be applied along 𝐺!   𝑎𝑛𝑑  𝐺! after the slice-select gradient. Phase-encode
gradients are used to encode columns within the 2D slab selected by the slice-select gradient,
as shown in Figure 1-9. The phase-encoding gradient, when applied to a system of spins,
enables the accumulation of phase. When the gradient is turned on, it changes the main
magnetic field slightly which leads to a slight change in the precession frequency of the
spins, and that frequency is a known linear function of spatial position. When the gradient is
turned off, the spins return to the original precession frequency but retain the phase
accumulated during the gradient. Variable amounts of phase encoding are applied after each
consecutive RF pulse to encode voxels in the axial slab to a unique position in the k-space.
The acquired signal from each voxel is sampled as a FID and is represented by one point in
k-space. The Field of View (FOV) in the direction that phase-encode gradient is applied is
given by:
1
𝐹𝑂𝑉! =    𝛾
,
∆𝐺
  
∙
  
𝜏
!
!"
2𝜋

[33]
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where ∆𝐺! is the phase-encode gradient step in either 𝐺! or 𝐺! direction that is turned on for
a time 𝜏!" .
The frequency-encode gradient is applied along 𝐺! or 𝐺! to encode the spatial localization of
spins. It is typically applied during signal read-out along just one direction to encode
columns within the selected 2D slab. Use of phase encoding and frequency encoding
gradients in a mutually orthogonal direction within the 2D selected slab leads to spatial
encoding of the voxels. The FOV in the frequency-encode direction is given by:
1
𝐹𝑂𝑉! =    𝛾
,
𝐺
  
∙
  
𝜏
!
!
2𝜋

[34]

where, 𝐺! is the amplitude of frequency-encode gradient applied for a time 𝜏! . Formation of
the MRI image with the use of gradient magnetic fields is described in the next section.
Figure 1-9 also shows a pulse sequence-timing diagram that provides a visual representation
of the order of gradients during a gradient echo sequence.

1.7.9 Gradient Echo Imaging
2D gradient echo imaging is a basic MRI pulse sequence used to form an MRI image.
Gradient echo imaging starts with a RF pulse turned on simultaneously along with the sliceselect gradient to select a 2D slab within a 3D volume as shown in Figure 1-9. The sliceselect gradient is applied along 𝐺! such that the thickness of the selected 2D slab is given by
equation [32]. Next, a phase-encode gradient is turned on along 𝐺! following the slice select
gradient. This enables phase accumulation for a column in the selected 2D slab. Following
phase encoding, a frequency-encode gradient is turned on along 𝐺! . A pre-phase gradient
with negative amplitude is turned on at the same time as the phase-encode gradient. A
readout gradient is turned on following the pre-phase gradient during which the data is
acquired. The read-out gradient has twice the area of the pre-phase gradient so that the
gradient echo occurs at the center of the readout gradient. This phenomenon along with the
full pulse sequence is shown in Figure 1-9. The time between RF pulse and the center of
readout gradient is called the Echo Time (TE). The time for repetition of the pulse sequence
is called the Repetition Time (TR).
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Figure 1-9: Pulse sequence diagram for gradient echo imaging (left) and corresponding
sample k-space trajectory (right).

1.7.10

Chemical Shift Imaging

Chemical Shift Imaging (CSI) is also known as Magnetic Resonance Spectroscopic Imaging
(MRSI) as it enables the acquisition of spectra spatially localized to a volume element, or
voxel. It uses phase encoding gradients only to encode the voxels in order to preserve the
chemical shift of the constituent chemical species. Spectra from each voxel contain the
information about chemical shift of an array of metabolites and their relative magnitude
within that voxel. A pulse sequence for 2D-MRSI begins with the application of an excitation
RF pulse and a slice-selective gradient 𝐺! simultaneously. Following the excitation RF pulse
and slice-selective gradient, phase-encoding gradients are applied in the other two
dimensions to encode voxels within the plane of the selected axial slab. Assuming both
phase-encode gradients are turned on for a time 𝜏 with different amplitudes 𝐺! and 𝐺! as
shown in Figure 1-10, the position in k-space is represented as following:
!

!

𝑘!! = 𝑎! !! 𝐺!    ∙   𝜏 , and 𝑘!! = 𝑎! !! 𝐺!    ∙   𝜏 ,

[35]

where 𝑎! is the amplitude of phase-encode gradients used for each encoding step. The total
number of points in each direction in k-space determines the resolution of 2D-MRSI for a
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given FOV. The FOV in the x- and y-direction is also a function of phase-encode gradient
step and the time that it is turned on for 𝜏, such that:
1
1
𝐹𝑂𝑉! =    𝛾
  , and  𝐹𝑂𝑉! =    𝛾
,
∆𝐺
  
∙
  𝜏
∆𝐺
  
∙
  𝜏
!
!
2𝜋
2𝜋

[36]

where ∆𝐺! and ∆𝐺! are the x- and y-direction phase-encode gradient steps respectively. Once
k-space is fully acquired, a 2D inverse Fourier transform is performed on the k-space data to
reveal the MRSI data.

Figure 1-10: Pulse sequence for 2D-MRSI and corresponding k-space filling are shown. The
RF pulse and the slice select gradient are played out simultaneously and lead to the selection
of an axial slab. Phase-encode gradients are applied to encode all voxels, one by one in the
selected slab. k-space is organized such that each point in k-space represents a FID. Adapted
from reference (73).

1.7.11 Dixon Approach to Image Chemical Species with a Sparse
Spectrum
The Dixon approach has been used extensively to image chemical species with a sparse
spectra. It is usually based on a gradient echo type of pulse sequence where the
reconstruction to formulate final images relies on known chemical shifts between the
chemical species. Gradient echo based pulse sequences generally read-out an entire k-space
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line after the excitation RF pulse compared to one k-space point in CSI and as a result are
significantly faster. The echo times in the gradient echo sequence are selected such that the
chemical species with known chemical shifts appear in-phase or out-of-phase with respect to
each other. The Dixon approach was first used to separate water and fat that resonate 3.5 ppm
apart in proton MRI. A two point Dixon approach to separate water and fat is demonstrated
by Figure 1-11. The transverse magnetization of water and fat behave differently due to the
difference in their chemical shifts. The net magnetization of fat goes in and out of phase
when the frequency of the rotating frame of reference is fixed at the resonant frequency of
water. Proper selection of echo times ‘a’ and ‘b’ provide a net image at ‘a’, which is the sum
of in-phase water and in-phase fat. Similarly, the total image at ‘b’ is the sum of in-phase
water and out-of-phase fat signals. The images at ‘a’ and ‘b’ are added together in a complex
fashion to yield a pure water image and subtracted in a complex fashion to yield a pure fat
image. (74)
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Figure 1-11: Imaging at echo times ‘a’ and ‘b’ results in a net image of in-phase water and
in-phase fat at ‘a’ and in-phase water and out-of-phase fat at ‘b’ respectively. These images
when added and subtracted together provide a pure water and fat image. Adapted partially
from reference (74).
Three echoes can be collected using the Dixon approach to correct for 𝐵! inhomogeneities in
addition to separation of water and fat phases. (75) This helps with the reduction of error
associated with accurate quantification of the chemical species in a non-uniform 𝐵! field
map. The Dixon approach of Iterative decomposition of water and fat with echo asymmetry
and least squares estimation (IDEAL) has been used extensively to separate water and fat
images, (76) and can be based on a gradient echo pulse sequence approach. (77) It improves
upon the traditional Dixon approach by incorporating a parameter called number of signals
averaged. This parameter can be optimized by the choice of echo times, which optimizes the
overall SNR and quantification of chemical species. (78)
The IDEAL technique has been used with hyperpolarized 13C-pyruvate to separate pyruvate
and the downstream metabolites. (79) A novel application of the IDEAL technique used to
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separate 13C-bicarbonate and 13C-carbon dioxide images to construct a ratio metric pH map is
presented in Chapter 3.

1.8 Hyperpolarized 13C-pyruvate Magnetic Resonance
Metabolic Imaging
MRI signal is dependent on the net magnetization that aligns with the external magnetic
field. The magnetization in turn is proportional to the polarization as described in equation
[16]. Typically, with an external magnetic field of 3T, using equation [14], the thermal
polarization of protons is 10 ppm or 0.001 %. Clinical MRI has been very successful at
anatomical imaging as the poor polarization is compensated by the high concentration of
protons in vivo. Other nuclei with spin =1/2 (3He,

129

Xe,

13

C) can be used with MRI but

typically the polarization and the concentration are the limiting factors. For example: 13C has
a natural abundance of only 1.1 % and a gyromagnetic ratio of ¼ compared to protons (Table
1-2) significantly limiting SNR. Improvement in polarization methods has led to the
emerging field of hyperpolarized-MRI. Hyperpolarized Noble Gas (HNG) MRI for lung
imaging uses
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Xe and 3He that are polarized 4-5 orders of magnitude greater than the

corresponding thermal equilibrium. (80) Spin exchange optical pumping is typically used for
polarization of HNG. (81) Imaging metabolism coupled to a particular enzyme-catalyzed
reaction in vivo has been made possible with hyperpolarized
hyperpolarization of

13

13

C-MRI. (1) The

C-substrates can be attained either by para-hydrogen induced

polarization process (82) or Dynamic Nuclear Polarization (DNP) process. (83) DNP is the
more frequently used method and has been used to polarize both 13C-substrates (13C-pyruvate
and 13C-bicarbonate) used for 13C-MRI in Chapters 2, 3 and 4.

1.8.1 Dynamic Nuclear Polarization Method
DNP is based on polarization of nuclear spins in the solid state. Unpaired electrons are
required as one of the ingredients to assist with the process. Overhauser first discovered this
phenomenon where highly polarized unpaired electrons under the influence of a microwave
irradiation source transfer their polarization to the nuclear spins. (84) The phenomenon came
to be known as the Overhauser effect. The interested reader is referred to (85-87) for the
exact theory on the quantum mechanical interaction between the electrons and nuclei under
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the influence of a microwave irradiation source. The physical conditions best suited for
achieving high polarization are low sample temperature, high magnetic field around the
sample and irradiation with a microwave source. The sample is prepared as a mixture of
unpaired electrons, glycerol and the

13

C-substrate. A homogeneous distribution of electrons

is one of the most important considerations for the sample preparation. The source of
unpaired electrons is typically an organic free radical. Glycerol is added as a glassing agent
to achieve homogeneous distribution of unpaired electrons and to obtain an amorphous solid
after cooling the sample. For in vitro and in vivo use, after polarization in the solid state at
low temperature, the sample is quickly brought into a liquid state at room temperature. (83)
The commercial DNP system (Hypersense, Oxford Instruments, UK) used for research
presented in this thesis polarizes

13

C-substrates at very low temperature (1.4 Κ), high

magnetic field (3.35 T) and in the presence of microwave irradiation (~94 GHz). This
process is depicted in Figure 1-12. The specific recipes for 13C-pyruvate and 13C-bicarbonate
preparation and polarization are discussed in Chapters 2 and 3.
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Figure 1-12: Illustration above shows homogeneous distribution of electrons within the 13Cnuclei for efficient polarization. The amorphous solid is irradiated with a microwave source
(as shown by arrows ~94 GHz) at high magnetic field and low temperature to achieve desired
polarization.

1.8.2 Metabolism of Hyperpolarized 13C-pyruvate
13

C-pyruvate is used as a probe to image the metabolism of the endogenous pyruvate. It is

quite suitable as it offers a high degree of polarization, good water-solubility and a
sufficiently long relaxation time in vivo. Hyperpolarized

13

C-pyvuate has been used

extensively to study pre-clinical cancer models. It has also demonstrated useful results in
phase I clinical trials in an application towards prostate cancer in humans. (2) In vivo
metabolism of intravenously injected hyperpolarized 13C-pyruvate is demonstrated by Figure
1-13. Injected 13C-pyruvate is shuttled past the cell membrane and arrives at the intersection
of three major metabolic pathways. In healthy cells, most of the pyruvate, which is derived
from glucose, is shuttled to the mitochondria where it produces energy by aerobic respiration.
Under hypoxic/ischemic conditions, cells switch over to anaerobic respiration where Lactate
Dehydrogenase (LDH) readily converts pyruvate to lactate. Pyruvate also undergoes
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transamination to form alanine, catalyzed by Alanine Transaminase (ALT) in the cytoplasm.
13

C-pyruvate that is shuttled into mitochondria also leads to irreversible production of

carbon dioxide, which readily equilibrates with

13

13

C-

C-bicarbonate, catalyzed by Carbonic

Anhydrase (CA).
Imaging endogenous enzyme catalyzed pyruvate to lactate conversion with the use of
hyperpolarized 13C-pyruvate provides insight into the level of anaerobic respiration. The total
MRI signal for

13

C-pyruvate and the by-product

concentration and amount of

13

13

C-lactate depends on initial polarization,

C-pyruvate injected, in vivo relaxation (13C-pyruvate,

13

C-

lactate) and pool size of endogenous pyruvate and lactate. To quantify the LDH enzymatic
reaction, 13C-Lactate to 13C-Pyruvate Signal Ratio (Lac/Pyr) is derived where the total lactate
signal to total pyruvate signal is normalized. This factor provides a reliable quantification of
the anaerobic metabolism and has been used in Chapters 2 and 4 to capture early RP
metabolism in RILI rat model.
The conversion between 13C-carbon dioxide and 13C-bicarbonate is highly dependent on pH
as bicarbonate is the largest extracellular buffer in vivo. 13C-bicarbonate can also be polarized
by DNP and administered intravenously. As a result, imaging of 13C-carbon dioxide and 13Cbicarbonate can provide insight into the pH of the immediate extracellular environment. This
concept formed the basis for Chapter 3 in which, a novel pH imaging approach based on the
Dixon method is discussed in detail.
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Figure 1-13: Injected hyperpolarized 13C-pyruvate results in 13C-lactate, 13C-alanine, 13Ccarbon dioxide and 13C-bicarbonate. Up-regulation of anaerobic respiration in hypoxic tissue
environment leads to a higher production of lactate that can be quantified by the factor,
lac/pyr.

1.8.3 Data Acquisition Considerations for Hyperpolarized 13C-MRI
The net detectable signal from administered

13

C-substrates and the subsequent by-products

are a function of their longitudinal relaxation times, concentration and initial polarization of
the injected

13

C-substrate. As the polarization in the parent molecule and its metabolites

decays fast due to short T1 relaxation times (e.g. 13C-pyruvate ~40 s in vivo), imaging time is
one of the primary constraints for 13C-MRI. Typically, the CSI sequence used to acquire data
for research presented in this thesis took ~12 s after a wait time of 25 seconds from the start
of intravenous injection of 13C-pyruvate. The wait time is sufficient to allow 13C-pyruvate to
clear out from the vasculature as it is absorbed by the cells and converted into 13C-lactate. A
secondary consideration for pulse sequences is the number of RF pulses used to acquire each
dataset. A minimal number of RF pulses is preferred as each RF pulse causes a loss of
unrecoverable polarization. The relative amplitude of each RF pulse is also calibrated
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carefully as the amount of polarization lost also depends on the flip angle that each RF pulse
generated. For example, the in vivo acquisition of CSI dataset in this thesis used 144 RF
pulses with a 10-degree flip angle for each RF pulse.

1.9 Thesis Hypothesis and Objectives
The objective of this thesis was to investigate metabolic changes occurring in rat lungs
during RP. As metabolic changes precede morphological and functional changes, assessment
of metabolic profile could help in early diagnosis of RILI. Hyperpolarized 13C-MRI with its
ability to polarize variety of 13C-substrates was used to quantify metabolism during RP. 13Csubstrates of

13

C-pyruvate and

13

C-bicarbonate were used to study enzyme-catalyzed

reactions. We hypothesize that hyperpolarized

13

C-MRI can be used to detect metabolic

changes in early RP which correlate with the known histological transformations. The subobjectives established for this purpose are included as part of the manuscripts and
Appendices that follow.
This chapter has described the motivation for the study of unintended lung injury caused by
therapeutic radiation of the lung cancer. An overview of lung cancer, radiation therapy and
the pathophysiology of RILI have been described. Clinical diagnosis and emerging imaging
modalities for detection of RILI have also been discussed. MRI physics of pulse sequences
used for the research in this thesis such as Chemical Shift Imaging, gradient echo imaging
and the IDEAL method were explained. Introduction to the DNP process used for
polarization of

13

C-substrate and the use of

13

C-pyruvate and

13

C-bicarbonate to probe

particular metabolic pathways was described in a biological context.
Chapter 2 describes the validation of detection of metabolic signature in early RP using
hyperpolarized

13

C-pyruvate. Six rats were irradiated in the entire thorax region with a

cobalt-60 source (dose of 14 Gy, 1 fraction) and imaged two weeks later along with healthy
age-matched controls. Results were analyzed for change in lac/pyr in the irradiated cohort
compared to the healthy cohort and histology was used as a confirmation for the presence of
injury. Kundan Thind was responsible for construction of a

13

C-birdcage coil and a 1H-

surface coil in addition to the experimental design, testing of protocols, animal preparations,
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experimental data acquisition and analysis. Dr. Alexei Ouriadov provided assistance in
optimization of the RF coils and the pulse sequences. Dr. Eugene Wong and Dr. Matthew
Fox assisted with the irradiation procedure. Dr. Lanette Friesen-Waldner assisted with the
animal preparation and in polarization of the

13

C-pyruvate. Dr. Albert Chen was pivotal in

providing numerous discussions and the technical guidance for the study. Dr. Eugene Wong
and Dr. Jake Van Dyk provided meaningful discussion about the work. Dr. Giles Santyr
provided overall guidance for the project and assistance with the manuscript presentation.
This

work

has

been

published

in

Magnetic

Resonance

in

Medicine.

(DOI:

10.1002/mrm.24525)
Chapter 3 expands on the findings in Chapter 2. The objective for this Chapter was to capture
metabolic profile in early RP in a regional and longitudinal manner and correlate the changes
to histology. To capture regional metabolic changes, MRI hardware was improved by
construction of a TORO coil system that enabled an increase in SNR of 3-4x over the
transmit-receive RF coil configuration. This has been described in Appendix A-1. Twelve
rats were irradiated in a conformal manner to the right lung using a micro-CT system.

13

C-

data was collected at day 5, 10, 15 and 25 post irradiation from three irradiated and three
healthy age-matched control animals. Macrophage count from the histology of rat lungs was
obtained and correlated with changes in lac/pyr. Kundan Thind was responsible for
construction of the

13

C-TORO coil system (Appendix A-1) in addition to the experimental

design, experimental data acquisition and analysis. Michael Jensen assisted with the
irradiation procedure using micro-CT. Dr. Francisco Martinez and Dr. Tim Scholl assisted in
the polarization of

13

C-pyruvate for the experiments. Elaine Hegarty performed the animal

preparation pre-MRI and obtained histology post-MRI. Dr. Albert Chen was pivotal in
providing numerous discussions and the technical guidance for the study. Dr. Eugene Wong
and Dr. Jake Van Dyk provided meaningful discussion about the work. Dr. Giles Santyr
provided overall guidance for the project and assistance with the manuscript presentation.
This work has been submitted to the journal of Radiotherapy and Oncology. (August 2013:
RO-D-13-00907)
Chapter 4 describes a novel method to map pH using hyperpolarized

13

C-bicarbonate with

the IDEAL pulse sequence. Maintenance of pH balance is one of the most essential
homeostatic processes in vivo, disruption of which could lead to severe adverse affects. The
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disruption could be caused by onset of cancer, metabolic and respiratory acidosis and
alkalosis. In particular, onset of severe RILI could lead to hypoxic tissue environment that
would result in a build-up of lactic acid. Accumulation of lactic acid in the tissue results in an
acidic tissue environment. Non-invasive pH mapping could potentially help with diagnosis of
RILI and other diseases that result in pH imbalance. The IDEAL pulse sequence was used to
map

13

C-bicarbonate and its downstream metabolite of

13

C-carbon dioxide. These form an

acid-base pair and the ratio of 13C-bicarbonate to 13C-carbon dioxide aids in the construction
of the pH map. Kundan Thind was responsible for construction of the phantoms,
experimental design, experimental data acquisition and analysis. Dr. Francisco Martinez and
Dr. Tim Scholl assisted in the polarization of

13

C-bicarbonate for the experiments. Curtis

Weins provided assistance with the IDEAL pulse sequence. Dr. Albert Chen was pivotal in
providing numerous discussions and the technical guidance for the study. Dr. Giles Santyr
provided overall guidance for the project and assistance with the manuscript presentation.
This work will be submitted to the journal of Magnetic Resonance in Medicine.
Chapter 5 discusses the results from the three preceding manuscripts and their contribution
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Chapter 2: Detection of Radiation-induced Lung Injury
using Hyperpolarized 13C Magnetic Resonance
Spectroscopy and Imaging

K. Thind, A. Chen, L. Friesen-Waldner, A. Ouriadov, T. J. Scholl, M. Fox, E. Wong, J.Van
Dyk, A. Hope, and G. Santyr
Magnetic Resonance in Medicine. September 2012. DOI: 10.1002/mrm.24525

2.1. Introduction
Lung cancer was the most commonly diagnosed cancer in males in 2008 globally, and fourth
most commonly diagnosed cancer in females. It was also responsible for the largest number
of cancer related deaths in 2008. (1) Radiation therapy is as an important treatment method
for lung cancer, (2) but can lead to RILI, as the lung is an extremely radiosensitive organ. (3)
RILI begins with inflammation of the lung referred to as RP, which is the most common
dose-limiting factor for thoracic radiation therapy and develops in as many as 37% of
patients receiving radiation for lung cancer. (2, 4, 5) Anatomical and functional changes
associated with RILI include capillary damage, obstruction of airways and thickening of the
septa, resulting in ventilation-perfusion mismatch. RILI can present with shortness of breath,
cough, or fever and may require oxygen therapy, ventilator support or even cause death in
extreme cases. (6) If changes associated with RILI could be detected, a given radiation
therapy plan could potentially be altered to reduce adverse effects. Furthermore, medical
intervention in patients developing RP maybe be possible if the injury process can be
detected at an early stage. (7)
At the cellular level, immunohistochemical analysis of the irradiated lung reveals
macrophage infiltration and activation of inflammatory cytokines. (8, 9) It has also been
shown that lung hypoxia is an important contributing factor in the mediation of the
inflammatory process and onset of the RP phase of RILI. (10) Decreased paO2 has also been
reported following irradiation (11, 12), an indicator of hypoxia. (13)
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CT is currently the most common modality used to detect RILI in the clinic. CT can measure
lung tissue density changes associated with late-stage RILI, but provides no functional
information. (9) Technetium-99m SPECT can provide regional ventilation and perfusion
changes with the onset of RILI but lacks specificity. (14) Dynamic contrast-enhanced MRI
with Gd-DTPA has been used to detect changes post-irradiation in dog lungs. (15) MRI has
also been able to measure significant changes in relaxation times (T1 and T2) post-irradiation
in rodent lungs. (16) Hyperpolarized 3He MRI has also been able to detect significant
changes in the Apparent Diffusion Coefficient (ADC) values in rodent lungs post irradiation.
(17) These imaging techniques show improvement over global paO2 measurements but are
primarily based on late-stage morphological and functional changes (e.g., fibrosis). Imaging
biomarkers sensitive to early metabolic changes associated with RP (e.g., inflammation and
hypoxia) at the cellular level could provide an approach for earlier detection and treatment of
RILI.
Recent advances in technology have enabled increases in the MRI signal from 13C-enriched
substrates by a factor of more than 105 using the DNP and dissolution method. Moreover, the
signal intensity is enhanced for both the initially hyperpolarized substrate as well as many of
its metabolic products. (18-20) Specifically, pyruvate enriched to

13

C at the C-1 position of

the molecule, can be hyperpolarized to a high via DNP and has sufficiently long T1 for
subsequent imaging in vivo. This enhanced polarization provides sufficient signal for high
spatial and temporal resolution imaging of pyruvate and its metabolic products. (21-24)
Several studies have demonstrated hyperpolarized

13

C to be useful for studying changes in

metabolic exchange/conversion of pyruvate to lactate, alanine and bicarbonate in vivo. (2530) The feasibility of using hyperpolarized [1-13C] pyruvate and lactate signals to measure
metabolic changes associated with lung ischemia has been shown ex vivo. (31) Measuring
changes in hyperpolarized [1-13C] pyruvate and lactate signals may be a useful approach for
non-invasive detection of RILI at an early stage in vivo. Specifically, hypoxia during RP is
expected to increase the level of anaerobic respiration to meet the constant energy needs of
the tissue, which in turns leads to a higher level of lactate. We hypothesize that lactate-topyruvate signal ratio in the lung as measured by hyperpolarized

13

C Magnetic Resonance

Spectroscopy (MRS) and MRSI will increase following thoracic irradiation due to the onset
of hypoxia and up-regulation of anaerobic respiration and will correlate with a decrease in
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paO2.
In this study, lactate-to-pyruvate signal ratios were measured using hyperpolarized

13

C

spectroscopy and imaging in rats two weeks post whole-thorax irradiation (n = 6) and
compared to lactate-to-pyruvate signal ratios obtained from healthy, age-matched rats (n =
6). RILI induced inflammation and hypoxia were confirmed using microscopy of
bronchoalveolar lavage (BAL) specimens and by measurement of paO2 using blood sampling
respectively. Dynamic spectroscopy was first performed over the entire thorax and kidney
region to reveal the time course and total pyruvate and lactate levels. 2D-CSI was then
performed at the optimal time window to quantify regional pyruvate and lactate signal
intensities specifically in the heart and in the lung.

2.2. Methods
2.2.1 Animal Irradiations
All procedures followed animal care protocols approved by the University of Western
Ontario (ACVS) and were consistent with procedures approved by the Canadian Council on
Animal Care (CCAC). To induce RILI, Sprague Dawley rats (weight = 350 ± 50 g) were
irradiated with a dose of 14 Gy delivered uniformly using a

60

Co source at the London

Regional Cancer Program center. A 4 cm diameter collimator was used to deliver the
radiation to the entire thorax. Animals were anesthetized using isoflurane delivered with a
nose cone and were secured in a polyvinyl box that served as a build up layer for the
beam. The setup is shown in Figure 2-1.

60

Co
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Figure 2-1: a) Photograph 60Co irradiator with animal positioning system and the isoflurane
vaporizer. b) Irradiator seen from top view showing custom-built animal holding box and the
lead collimator with an opening of 4 cm.
A pilot study involving eight separate rats irradiated with either 12 or 18 Gy was used to
assess the appropriate whole lung radiation dose to be used in the final cohort study. A single
fractionation of 14 Gy was chosen as a compromise in order to induce RILI while ensuring
survival following irradiation. To provide a uniform dose, 7 Gy was delivered with the
animal in the supine position and 7 Gy was delivered with the animal in the prone position.
Animals were returned to their cages and monitored daily for two weeks following the
irradiation. A total of twenty rats were irradiated, of which six were used for
MRS and CSI of of the thorax, five were used for

13

13

C dynamic

C dynamic MRS of the kidneys, five

were used for assessment of paO2 and four were used to measure blood lactate concentration
(as described further below). An equal number of age-matched healthy Sprague Dawley rats
were used as controls for each measurement performed. Details for each sub-study are
described below.

2.2.2 Blood Lactate and paO2 Measurement
In order to confirm the presence of RILI, paO2 levels were measured in an age-matched,
irradiated cohort (n = 5) two weeks following irradiations and in a healthy cohort (n = 5). The
two-week time point was chosen to yield maximum effect, based on the inflammatory and
biochemical time course of RILI in a similar rat model shown in previous work by Calveley
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et al. (8) Animals were initially anesthetized in an isoflurane induction chamber (Vet-Equip)
at a flow rate of 0.8 L / min using a concentration of 5% isoflurane and were then transferred
to a nose cone where the isoflurane concentration was reduced to 2% and a loading dose of
ketamine hydrochloride was given at a dose of 50 mg/kg. A 26 gauge catheter was inserted
into the right tail vein to facilitate prolonged anesthesia depth by delivery of a mixture of
propofol and ketamine at a ratio of 10:1 using an infusion pump with a dose rate of 50
mg/kg/hr. An incision was made across the neck in order to expose the right carotid artery,
which was then isolated and cannulated with PE-50 tubing to allow arterial blood sampling
and monitor blood pressure. A 0.75 mL blood sample was then extracted and inserted into a
CG4+ iStat cartridge for blood oxygenation analysis (iStat blood gas analyzer, Abbott
Laboratories).
In order to investigate potential systemic (ie. blood) RILI effects, that may influence the
hyperpolarized

13

C metabolic imaging studies, blood lactate concentration levels were

measured directly from blood samples obtained in another age-matched cohort (n = 4) two
weeks following irradiation as well as a healthy cohort (n = 4). Animals were initially
anesthetized in an isoflurane induction chamber (Vet-Equip) at a flow rate of 0.8 L / min
using a concentration of 5% isoflurane and were then transferred to a nose cone where the
isoflurane concentration was reduced to 2%. A 26-gauge catheter was inserted into the tail
artery to draw 0.5 ml of blood. This blood sample was then extracted and inserted into a
CG4+ iStat cartridge for blood lactate concentration analysis (iStat blood gas analyzer,
Abbott Laboratories, Mississauga, ON).

2.2.3 Hyperpolarized 13C pyruvate Preparation and Administration
A mixture containing ~30 µl of [1-13C]-labelled pyruvic acid (CIL, Cambridge, MA) and
15mM trityl radical (OX63, Oxford Instruments, UK) was hyperpolarized using a
commercially-available DNP system (Hypersense, Oxford Instruments, UK) following a
previously described protocol (24). In brief, the DNP system utilizes low temperatures (1.4
K), high magnetic field strength (3.35 T) and microwave irradiation (94.15 GHz) to polarize
the unpaired electrons in the radical that transfer the magnetization to 1-13C in the pyruvate
molecule via the Nuclear Overhauser Effect (NOE) in the solid state. The hyperpolarized
sample was rapidly dissolved in ~5.5 ml buffered (40 mM Tris) solution containing 80 mM
Sodium Hydroxide, 0.1g/L Disodium EDTA dehydrate and 50mM Sodium Chloride to
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effectively yield a 80 mM hyperpolarized pyruvate with a nominal pH of 7.4 upon
dissolution.
MRI and spectroscopy were performed approximately two weeks (14 days ± 2 days)
following irradiation. The experiments extended over four days to permit all twenty-two (11
irradiated and 11 control) animals to be studied at approximately the same time postirradiation. The mean mass of the irradiated and healthy cohorts at the time of imaging was
410 ± 50 g. Each rat was randomly chosen and measurements were made in a blinded
fashion. On the day of measurements, the rats were anaesthetized using isoflurane. A catheter
was inserted in the tail vein for injection of hyperpolarized 13C-pyruvate. The extension tube
connecting the catheter to the hyperpolarized sample was 24-gauge and 90 cm in length. This
tube made it possible to quickly inject the hyperpolarized sample while minimizing the dead
space. Since the hyperpolarized pyruvate signal relaxes relatively quickly (T1 ~40 s) in
vivo, MR spectroscopy data acquisition was started (as described below) immediately
following bolus injection of 2.5 mL of 80 mM [1-13C] pyruvate in the tail vein of the rats (~
12 s). MRI data were acquired following a time delay (~ 25 s) to maximize lactate signal
in the lung. This optimal time delay was based on the observed plateau in lactate signal
measured with dynamic spectroscopy (see below).

2.2.4 Magnetic Resonance Spectroscopy and Imaging
MRI and spectroscopy were performed using a 3T MRI system (MR750, GEHC, Waukesha,
WI) equipped with multinuclear hardware and software. The rat was supported in the bore of
the magnet in the prone position using a custom tray equipped with a warming pad to
maintain body temperature. A surface coil centered on the rat chest was fastened underneath
the tray to acquire 1H images for localization purposes. The tray and surface coil were
inserted into a custom-built, rat-sized quadrature transmit/receive bird-cage coil tuned to the
13

C Larmor frequency of 32.12 MHz. During MR measurements, the rats were kept

anaesthetized with isoflurane (2 - 2.5%) provided by a nose cone delivery system. Heart rate
(320 - 360 beats per minute), breathing rate (40-60 breaths per minute) and core body
temperature (37.0 - 37.8 °C) were monitored during the entire procedure (Small Animal
Instruments Inc., Stony Brook, NY).
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(A) 1H imaging: A gradient echo pulse sequence was used to acquire 1H images of the rat
chest and kidney in the coronal and axial planes. The imaging parameters were as follows:
FOV of 12 cm × 12 cm, matrix of 128 ×128, TE = 2 ms and TR = 34 ms, flip angle = 30
degree. These images were used to position the 13C data acquisition slabs and FOV since the
boundary of the lung was well visualized as a signal void compared to the other thoracic
tissues (e.g. heart).
(B) 13C Dynamic Spectroscopy: Based on the 1H coronal images, an axial slab (thickness =
8.5 mm) was selected in medial regions of the lung, including the heart. Spectroscopic data
were acquired from this slab in the irradiated cohort (n = 6) and healthy cohort (n = 6) using
a ‘pulse-acquire’ pulse sequence with TR of 1 s following the injection of hyperpolarized
13

C-pyruvate. In total, 128 acquisitions were performed using flip angle = 10 degree,

bandwidth = 5 kHz and 2048 points for a total scan time of 128 s. This dynamic spectroscopy
data allowed measurements of total 13C signal in the slab as well as the time evolution of the
pyruvate and lactate signals in order to time the spectroscopic imaging data acquisitions
(described in section (C) below).
To investigate possible indirect RILI effects outside the thorax, dynamic spectroscopy was
performed over the kidney region in a separate age-matched irradiated cohort (n = 5) and
healthy cohort (n = 5). An axial slab of thickness 10 mm was acquired in the region of the
kidney, using 1H coronal images as a reference.

13

C data were acquired with TR = 1 s, flip

angle = 10 degree, bandwidth = 5 kHz and 2048 points for a total scan time of 128 s.
(C)

13

C Spectroscopic Imaging: Spectroscopic imaging was performed using a CSI

technique from the same cohorts used in the

13

C dynamic MRS studies of the thorax in

irradiated rats (n = 4) and healthy rats (n = 4). A FOV of 6 cm × 6 cm was chosen
corresponding to the same axial slab as described in section (B) above. A 16 × 16 matrix was
prescribed with a nominal voxel size of 3.75 × 3.75 × 8.5 mm3. CSI data were acquired using
a similar pulse-acquire approach as described above (flip angle of 10 degrees, bandwidth of 5
kHz and 256 points) with a repetition time of 60 ms between each phase–encoding step for a
total scan time of approximately 16 seconds. Based on the

13

C dynamic spectroscopy
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measurements (above), spectroscopic imaging was initiated following a delay of 25 seconds
from the start of the bolus injection to maximize the lactate signal.
(D) Data processing and analysis: SAGE™ software (GEHC, Waukesha, WI) was used for
processing and visualization of the 13C data. For the dynamic spectroscopy protocol, the time
domain data from each transient was apodized with a 2.5 Hz Gaussian filter then Fourier
transformed. The spectra were then individually phased and baseline corrected. The lactateto-pyruvate signal ratio was computed by dividing the total pyruvate signal by the total
lactate signal intensities obtained from the entire thorax or the kidney slab of the rat by
integrating each metabolite peak at each time point and summing the peaks from 0 to 79
seconds, after which the signal intensities were too small to measure.
For the

13

C spectroscopic imaging data, the time domain data were apodized with a 10 Hz

Gaussian filter and Fourier transformed in both the time domain and the two spatial
dimensions. The metabolite peaks were phased and baseline corrected for every voxel. The
16x16 grid of spectra was overlaid on the axial 1H image and four voxels were chosen
centered on the lung region and four voxels centered on the heart. The relative positions of
these four voxels were kept consistent for both the heart and lung in each animal. The lactateto-pyruvate signal ratio for each voxel was computed by dividing the total pyruvate signal
intensity by the total lactate signal intensity obtained in a given voxel by integrating each
metabolite peak. Two-tailed, paired T-tests were performed for the lactate-to-pyruvate ratios
corresponding to the entire slab, as well as the lung and the heart for the irradiated cohort and
the healthy cohort. A p-value of less than 0.05 was considered significant. Appendix A-2
contains more details on the two-tailed paired T-test and the underlying assumptions.

2.2.5 Microscopy of BAL Specimens
Following MR measurements, BAL specimens were collected from the lungs of all the rats.
10 mL of saline was injected into the lungs using an endotracheal tube. The saline was
washed in and washed out three times to obtain a preliminary BAL specimen. This was
repeated again to obtain a second specimen and combined with the first to obtain a final
lavage specimen from the lungs. The BAL sample was then spun down at 1732 rpm for 10
minutes, while keeping the temperature at 8 °C to separate the pellet of cells from the

53

supernatant fluid using a centrifuge (GS-15R, Beckman Coulter, Mississauga, ON). The
pellet of cells was re-suspended in formalin and a smear placed on slides using a
cytocentrifuge (Shandon Elliott Cytospin, Shandon Southern Instruments, Camberley,
Surrey, England). The cell smears were subsequently stained with hematoxylin and eosin
(H&E) to identify cell nuclei (blue) from surrounding cytoplasm (pink). The slides were
visualized optically with a Zeiss AXIO Imager microscope (Carl Zeiss Canada ltd., Toronto,
ON, Canada). The cell micrographs for healthy and irradiated animals were compared to
provide a qualitative assessment of inflammation due to RILI.

2.3. Results
Figure 2-2 shows typical cell micrographs from a representative irradiated rat as well as a
healthy rat.

At 40× magnification, more macrophages are evident in BAL specimens

obtained from the irradiated cohort compared to BAL specimens obtained from the healthy
cohort. At 100× magnification, monocytes, foamy macrophages and neutrophils are clearly
seen in the BAL specimen from the irradiated cohort. Furthermore, some irregularities in the
cell nucleus shape are also evident in the cells from the BAL of irradiated rats. These results
qualitatively confirm the inflammatory response (i.e. RP) associated with RILI in the
irradiated rats at the two-week time point.
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Figure 2-2: Typical micrographs of H&E stained BAL specimens from (a) representative
healthy rat and (b) representative irradiated rat (magnification of 40×). The BAL specimens
from the irradiated rats contained significant macrophages compared to the healthy group
(shown by arrows). (c) BAL specimen from the representative irradiated rat seen at
magnification of 100×. Foamy macrophages (FM), monocytes (M) and neutrophils (N) can
be distinguished.
The paO2 results are summarized in Figure 2-3. In this figure, the mean value of paO2 is
shown with the error bars representing plus or minus one standard deviation based on the
entire cohort. A statistically significant decrease in paO2 (p < 0.01) was observed in the
irradiated cohort (54.2 ± 12.28 mmHg) compared to the healthy cohort (84.74 ± 9.98
mmHg). The low paO2 measured in the irradiated cohort compared to the healthy cohort
quantitatively confirms the presence of RILI, presumably causing tissue hypoxia.
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Figure 2-3: Arterial partial pressure of oxygen from cohort of healthy and irradiated rats at
two weeks.

Figure 2-4: Lactate concentration measured from direct sampling of blood from irradiated
and healthy rats. The lack of any significant difference confirms the absence of systemic
spread of injury.
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The blood lactate concentration levels are summarized in Figure 2-4. Mean lactate
concentration is shown with error bars representing the standard deviation within the cohort.
No statistically significant (p = 0.69) increase in blood lactate levels was observed in the
healthy cohort (1.255 ± 0.247 mmol/L) compared to the irradiated cohort (1.325 ± 0.214
mmol/L). Lack of a significant difference between blood lactate concentration levels between
the two cohorts confirms the absence of any systemic (ie. blood) increase in lactate due to
RILI.

Figure 2-5: Representative normalized spectra showing sum of metabolites from time 0 to
79 seconds over the entire slab from (a) healthy rat and (b) irradiated rat. Note the increase in
the level of lactate in the irradiated rat.
Figure 2-5 shows the summation of spectra from the hyperpolarized

13

C dynamic MRS

experiment from time 0 to 79 seconds corresponding to the entire slab in the lung region for a
representative healthy rat as well as a irradiated rat. Figure 2-6 shows representative 13C-CSI
data overlaid on the corresponding 1H image. The lactate-to-pyruvate signal ratio from the
13

C dynamic MRS data from the entire thorax was observed to increase in the irradiated

cohort (0.128 ± 0.041) compared to the healthy cohort (0.061 ± 0.019), representing a
statistically significant increase of approximately 110% in the entire thorax (p < 0.01).
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Figure 2-6: Axial proton image with localized 13C spectra magnitude overlaid on top with
highlighted voxels of interest in lung and heart. Clear pyruvate and lactate peaks are
observed in the heart and the lung region.
The lactate-to-pyruvate signal ratios corresponding to the lung, heart and kidney tissues for
both the healthy and irradiated cohorts are shown in Table 2-1. This table reports the mean
values and the error bars represent plus or minus one standard deviation based on the entire
cohort. The lactate-to-pyruvate signal ratios in the lung tissue were observed to increase in
the irradiated rats (0.280 ± 0.054) compared to the healthy rats (0.178 ± 0.046), representing
a statistically significant increase of approximately 57% (p < 0.02). Similarly, lactate-topyruvate signal ratio in the heart tissue also showed a statistically significant increase of
approximately 107% (p < 0.01) in the irradiated cohort (0.504 ± 0.083) compared to the
healthy cohort (0.244 ± 0.035).
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lactate/
pyruvate
Mean ±

Healthy

Irradiate

Healthy

Irradiate

Healthy

Irradiate

Healthy

Irradiate

thorax

d thorax

lung

d lung

heart

d heart

kidney

d kidney

(n= 6)

(n=6)

(n=4)

(n=4)

(n=4)

(n=4)

(n=5)

(n=5)

0.061 ±

0.128 ±

0.178 ±

0.280 ±

0.244 ±

0.504 ±

0.215 ±

0.215 ±

0.019

0.041

0.046

0.054

0.035

0.083

0.100

0.054

std. dev.

Table 2-1: lactate-to-pyruvate signal ratio measured in the entire thorax (summed from 0 to
79 seconds) as well as the lung, heart and kidney regions for healthy and irradiated rat
cohorts. The data is represented as the mean ± standard deviation based on the respective
cohorts. (Note: the lung and heart data for two of the rats had insufficient signal-to-noise
ratio and are not included in the table and the kidney data shown above is from separate but
identically irradiated and age matched healthy animal cohorts).
These are depicted in Figure 2-7. In the cohort of irradiated and control rats

13

C dynamic

MRS data from which a slab through the kidneys was acquired, no statistically significant
difference (p = 0.50) in lactate-to-pyruvate signal ratios between the healthy (0.215 ± 0.100)
and irradiated cohorts (0.215 ± 0.054) was observed.

Figure 2-7: Relative lactate-to-pyruvate signal ratio in the heart tissue and the lung tissue
displayed.

2.4. Discussion
To our knowledge this is the first time that hyperpolarized

13

C-pyruvate spectroscopic
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imaging has been applied in vivo to assess lung metabolism. Specifically, lactate-to-pyruvate
signal ratios are shown to be sensitive to metabolic changes associated with irradiation of the
thorax in rats. The lactate-to-pyruvate signal ratio increased significantly in irradiated rats
compared to age-matched, healthy rats. This increase in lactate-to-pyruvate signal ratio was
demonstrated both for the entire thorax and regionally in the heart tissue and lung tissue.
These increases are consistent with the expected changes in metabolism accompanying early
RILI, namely anaerobic glycolysis due to underlying hypoxia. These results are also
consistent with RP confirmed by micrographs of BAL smears reflecting a qualitative increase
in the numbers of inflammatory cells in the lung. Furthermore, the absence of any change in
lactate-to-pyruvate signal ratio in the kidney region nor any change in lactate levels in the
blood of similarly irradiated rats compared to healthy age-matched rats confirms that the
effects of injury are confined to the thorax region where radiation was directed and thus is a
direct measure of RILI.
A larger increase in lactate-to-pyruvate signal ratio was measured in the heart region of the
irradiated animals compared to the healthy animals as compared to the lung region. This
could have resulted from two possible factors. Firstly, the heart region is also irradiated in
addition to the lung region, presumably leading to direct cardiac damage due to radiation.
Secondly, due to the known compromise in lung function caused by the radiation as verified
by paO2 measurements and cell micrographs, it is possible that the heart rate increased to
compensate for low blood oxygenation to maintain the same amount of absolute oxygen
delivery to the cells. Increase in workload on the heart and decrease in paO2 leading to lower
paO2 in the coronary arteries could also potentially contribute to a higher lactate-to-pyruvate
signal ratio observed in the heart region compared to the lung region.
Hypoxia is expected in early RILI due to damage to blood vessels, especially in the lung,
which is a particularly radiosensitive organ. While not measured directly and independently
in this study, changes in lung perfusion due to RILI may also contribute to the increases in
lactate-to-pyruvate signal increases observed.

The sensitivity of blood vessels to high

radiation doses (i.e. hypofractionation) such as used in this study has been previously
reported in the literature (6). Hypoxia was confirmed in this study by direct measurement of
significant paO2 decreases in the irradiated rat cohort (54.2 ± 12.28 mmHg) compared to the
healthy group (84.74 ± 9.98 mmHg). It has been well established clinically that a paO2 value
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of less than 60 mmHg can lead to tissue hypoxia. (13) Decreases in paO2 following irradiation
of lung tissue has been previously reported. (11, 12) These results suggest that enhanced
lactate-to-pyruvate signal ratio may reflect early onset of RILI and could be correlated with
the concurrent phase of RP. The advantage of this technique over clinical standards such as
paO2 measurement is that it provides a localized measurement related to radiation injury and
can potentially reveal regional variation in the severity of the injury. This is an important
consideration from a clinical perspective as most treatment plans for lung cancer employ
regional (i.e. conformal) radiation delivery. This study is a first step toward a longitudinal
study of the effects of radiation dose, conformity and fractionation scheme that may help
elucidate the mechanisms of RILI from a regional metabolism perspective. Other
hyperpolarized 13C substrates such as 13C-bicarbonate may also be useful to measure regional
changes in pH (32) associated with RILI and could provide information complementary to
changes in pyruvate metabolism.
Although data acquisition and post-processing were kept consistent within individual data
sets in this study, variations could have been introduced by subjective tasks between data
sets. In particular, phasing and baseline correction for spectra were performed manually. In
this study, signals were localized to regions of the lung or heart only, therefore partial
volume contamination from surrounding tissues was likely. The use of absolute fiducial
markers for choice of 2D-CSI voxels within the heart and lung regions may help reduce
variable partial volume effects in future. Sampling of BAL from the lungs and processing
was also subjective in nature and could also have contributed to the uncertainty in cell
micrographs. SNR could be improved by the use of even more sensitive surface coils, which
would also aid in improving spatial resolution and/or performing 3D localization in the lung
with the use of Echo Planar Spectroscopic Imaging (EPSI) (33, 34)
In summary, hyperpolarized

13

C-pyruvate spectroscopic imaging can detect increases in

lactate-to-pyruvate signal ratio in the lung and heart tissue of rats as early as two weeks
following whole-thorax irradiation. This is consistent with hypoxic tissue conditions and
radiation pneumonitis, as confirmed by decreased paO2 and increases in inflammatory cells
respectively in the irradiated animals compared to healthy rats. This study is an important
first step in quantifying regional RILI by modifying fractionation schemes and/or conformal
radiation therapy and/or applying adjuvant therapies for the mitigation of RP. Concurrent
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development of human hyperpolarized 13C approaches could pave the way for the clinical use
of this regional technique in future.
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Chapter 3: Mapping metabolic changes associated with
early Radiation-Induced Lung Injury post conformal
radiation therapy using hyperpolarized 13C-pyruvate
Magnetic Resonance Spectroscopic Imaging
K. Thind, M. D. Jensen, E. Hegarty, A. P. Chen, H. Lim, P. Martinez, J. Van Dyk, E. Wong,
T. J. Scholl2 and G. E. Santyr
A shortened version of the manuscript below has been submitted to the journal of
Radiotherapy and Oncology. August 2013. RO-D-13-00907

3.1 Introduction
Lungs cancer was the most prevalent type of cancer among men and the fourth most
prevalent type of cancer among women globally in 2008. It was also responsible for the
highest number of cancer related deaths in 2008. (1, 2) Radiation therapy is a primary
treatment method for lung cancer (3) but leads to additional adverse consequences as the
lungs are one of the more radiosensitive organs. (4) One of the major side effects of thoracic
radiation therapy is RILI, which begins with inflammation of the lungs known as RP and can
proceed to irreversible lung fibrosis in the later stages. (3) RILI occurs in up to 37% of lung
cancer patients receiving radiation therapy (3, 5, 6), with moderate to severe RILI in about
20% of patients. (7) Underlying anatomical and functional changes in RILI include
thickening of septa, capillary damage and obstruction of airways leading to ventilationperfusion mismatch. These changes lead to symptoms such as shortness of breath, cough,
fever and the need for oxygen therapy and ventilation support. (8, 9)
Early detection of RP using imaging could potentially improve outcomes by appropriate
modification of the radiation therapy treatment plan and/or administration of corticosteroids
to help reduce inflammation. (10) Chest X-ray and CT imaging are currently the most
commonly used methods for detection of RILI in the clinic. These techniques detect changes
in lung density and can be useful for evaluation of fibrosis associated with late stage RILI
stage, but generally provide no functional information. (11) SPECT using technetium-99m
can provide regional ventilation and perfusion changes associated with the onset of RILI but
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lacks specificity. (12) 3D-CT has been used to provide lung DVH parameters to predict the
development of RP. (13) The two most common DVH parameters used as predictors of RILI
are Vdose (percentage of CT-defined total lung volume receiving greater or equal than the
threshold dose) and mean lung dose (average dose of the CT-defined total lung volume).
However, these parameters have very low predictive powers. (3)
Despite the low proton signal afforded in the lungs, MRI has been used for detection of RILI.
Dynamic contrast-enhanced MRI with Gd-DTPA has been used to detect perfusion changes
post-irradiation in dog lungs. (14) MRI has also been able to measure significant changes in
relaxation times (T1 and T2) post-irradiation in rodent lungs. (15) More recently,
hyperpolarized 3He-MRI has been used to detect regional changes in ADC and gas exchange
associated with RILI in rodent lungs post irradiation. (16) Although these MRI developments
show promise, they are still predominantly based on morphological and functional changes,
which generally occur too late in RILI to mitigate. Imaging biomarkers sensitive to early
metabolic changes associated with RP at the cellular level could provide an approach for
earlier detection of RILI.
At a cellular level, immunohistochemical analysis of RILI animal models reveals underlying
changes in alveolar macrophages, inflammatory cytokines and type II pneumocytes. (17, 18)
It is known that inflammatory cells are recruited from outside the radiation field following
irradiation. (19) These infiltrating macrophages are a source of cytokines that are associated
with the onset of inflammation in early RP. (20) RILI has also been shown to occur both in
and out of the radiation field following conformal radiation therapy (21, 22), with the base of
lung showing higher radiosensitivity than the apex. (21-24) Conformal radiation therapy of
the base of the left and right lung leads to biphasic cytokine expression with the first wave
occurring 24 hours post irradiation and the second wave occurring 5-15 days post irradiation,
(25) along with DNA damage that occurs from a period of 3 days up to a period of 4 weeks
post irradiation. Additionally, tissue hypoxia in the lungs plays a role in mediation of
inflammatory process in RP. (26) Decreased paO2, which is used as an indicator of hypoxia
(27) has been reported following radiation therapy. (28, 29)
Advances in hyperpolarized MRI technology, specifically DNP, have enabled increases in
the signal from

13

C-substrates of a factor of up to 100,000, enabling in vivo detection with
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high sensitivity. (30) Hyperpolarized endogenous liquid 13C-substrates can be safely injected
into the bloodstream of animals and humans and the increased signal allows regional
detection of the distribution of the injected

13

C-labelled compounds and their metabolic

products in real time. (31, 32) The pyruvate molecule enriched with 13C at the C-1 position
has been used extensively since it can be polarized to a high degree and has a sufficiently
long T1 for in vivo imaging (~40 s). High resolution spatial and temporal imaging of the
conversion of

13

C-pyruvate to its metabolic products,

13

C-lactate,

13

C-bicarbonate and

alanine, has been observed in vivo. (33-37) Specifically, changes in

13

C-lactate to

13

C-

13

C-

pyruvate signal ratio (lac/pyr) have been used to measure lung ischemia ex vivo. (38) Our
research has previously demonstrated changes in lac/pyr in a rat model of RILI at two weeks
post whole thorax irradiation. (39) A longitudinal study of regional changes in metabolism
following conformal radiation therapy would be a useful next step in the understanding the
progression of RILI, specifically early detection of RP.
The purpose of this work was to quantify regional lac/pyr using hyperpolarized 13C MRSI in
a rat model of RILI involving conformal radiation therapy of the lungs, 5, 10, 15 and 25 days
post-irradiation. These results were compared to those obtained in healthy age-matched rats
and correlated with quantitative (i.e. cell counting) histological analysis of the lungs
following imaging. The potential origin of lac/pyr changes in RP is discussed in terms of
changes in cell populations, specifically macrophages.

3.2 Methods
3.2.1

Animal Irradiation

All procedures followed animal care protocols approved by the Western University (ACVS)
and were consistent with procedures used by the Canadian Council on Animal Care (CCAC).
To induce RILI, 12 Sprague Dawley rats (200 ± 50 g) were irradiated with a total dose of
18.5 Gy (two equal fractions of 9.25 Gy, 24 hours apart). The treatment plan consisted of two
14×14mm2 opposed beams, incident on the dorsal and ventral surfaces.
Irradiation was performed using a micro-RT system based on a modified micro-CT (GE
eXplore CT 120, GE Healthcare, Milwaukee WI USA), similar to a system previously
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described. (40-42) For the micro-RT application, the micro-CT system was upgraded with
the addition of a more powerful x-ray generator and computer-controlled variable aperture
collimator. Image-guidance was performed using both planar fluoroscopy and micro CT
scanning. The therapeutic beam had energy of 140kVp with a Half Value Layer (HVL) of 6
mmAl. It was filtered by 4.5 mmAl to harden the beam for deeper penetration. The beam was
pulsed at approximately 10% duty cycle, with pulse duration of 125 ms at 63 mA. The
resulting dose rate was approximately 0.15 Gy/min including additional cooling breaks.
Delivery of each fraction required approximately 1.5 hours, with 1 hour needed for
irradiation and the remainder for imaging and setup. The animals were imaged with
fluoroscopy prior to therapy to localize the right lung. The collimator jaws were set to place a
14x14mm2 field on the lower-medial right lung at end expiration such that the diaphragm and
heart were shielded. Figure 3-1 shows the simulated conformal dose distribution in the lungs
and heart region of rat thorax for a single fraction (9.25 Gy).

Figure 3-1: Calculated dose distributions shown in (a) axial plane, (b) coronal plane and (c)
sagittal planes. The yellow contour around the right lung represents the isodose line
corresponding to 9 Gy. Most of the heart region and left lung received minimal radiation
dose (< 0.5 Gy). The dose delivery was gated to the breathing cycle for accurate dose
deposition.
During the irradiation procedures, the rats were anesthetized using isoflurane initially in an
induction chamber at 5%, and then transferred to a nose cone at 1.5 – 2.5% at a gas flow rate
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of 1.0 L/min medical oxygen. Lacrilube® (Allergan Inc, Markham, Canada) was applied
gently to both eyes to reduce the effect of dehydration. Animals were placed supine on the
micro-RT couch and were kept warm during the irradiation using a heating pad. A small
animal monitoring system (Small Animal Instruments Inc., Stony Brook, NY) was used to
monitor core body temperature and detect the breathing cycle to trigger the beam for gated
delivery of the radiation. Breathing rate was kept consistent at 50-60 breaths per minute by
regulating the amount of isoflurane and dose was delivered only during the expiration phase
of the breathing cycle for better dose registration. Animals were returned to high efficiency
particulate air (HEPA) filtered cages after the procedure. An equal number of age-matched
healthy Sprague Dawley rats were also housed in HEPA filtered cages and were used as
controls for MRI, blood analysis and histological measurements.

3.2.2 Blood Lactate and paO2 Measurements
In order to investigate systemic effects of conformal radiation therapy, blood lactate
concentration levels were measured in the irradiated cohort (n = 3) and corresponding agematched healthy cohort (n = 3) at day 5, 10, 15 and 25-post irradiation. paO2 levels were also
measured in each animal to quantify hypoxia post irradiation, using 60 mmHg as a clinical
threshold to classify hypoxic tissue environment. (27) To obtain the arterial blood, animals
were initially anesthetized in an isoflurane induction chamber (Vet-Equip) at a flow rate of
0.8 L / min using a concentration of 5% isoflurane and were then transferred to a nose cone
where the isoflurane concentration was reduced to 2%. A 26-gauge catheter was inserted
into the tail artery and a 0.75 mL blood sample was then extracted and inserted into a CG4+
iStat cartridge for blood lactate concentration and paO2 measurement (iStat blood gas
analyzer, Abbott Laboratories, Mississauga, ON). Two-tailed paired T-tests were performed
on blood lactate concentration and paO2 level between the healthy and irradiated cohorts for
each time point. Appendix A-2 contains more details on the two-tailed paired T-test and the
underlying assumptions.

3.2.3 Hyperpolarized 13C-pyruvate Preparation, Administration and MRI
Approximately 30 µl of [1-13C]-labelled pyruvic acid (CIL, Cambridge, MA) was mixed with
15mM trityl radical (OX63, Oxford Instruments, UK) and was hyperpolarized using a
commercial DNP system (Hypersense, Oxford Instruments, UK). The hyperpolarization
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protocol has been described in detail previously. (43) During dissolution, the hyperpolarized
sample was readily dissolved in ~5.5 ml buffered (40 mM Tris) solution containing 80mM
Sodium Hydroxide, 0.1g/L Disodium EDTA dehydrate and 50mM Sodium Chloride to yield
a 80 mM hyperpolarized pyruvate with a nominal pH of 7.4.
MRI was performed on the irradiated cohort (n = 3) and corresponding age-matched healthy
cohort (n = 3) at day 5, 10 ± 1, 15 ±1 and 25 ± 1 post irradiation for a total of 12 irradiated
rats and 12 healthy rats. For each cohort, rats were randomly chosen and measurements were
performed in a blinded fashion. The rats were anesthetized using initial bolus of 5%
isoflurane at a flow rate of 0.8 L / min and were then transferred to a nose cone where the
isoflurane concentration was reduced to 2%. After blood lactate concentration and paO2
measurements, a catheter was inserted in the tail vein for injection of hyperpolarized

13

C-

pyruvate. The extension tube connecting the catheter to the hyperpolarized sample was 24gauge and 90 cm in length.

3.2.4 Magnetic Resonance Spectroscopy and Imaging
MRI and MRSI were performed using a 3T MRI system (MR750, GEHC, Waukesha, WI)
equipped with multinuclear hardware and software as described previously. (39) The animal
was supported in the prone position with a custom-built tray equipped with a warming pad to
maintain body temperature. They tray included a nose cone that supplied 2 – 3% isoflurane at
0.8 L/min flow rate to maintain anaesthesia during the experiment. A custom surface coil
resonant at the

13

C Larmor frequency (32.12 MHz) was wrapped around the animal thorax.

The tray was then inserted into a custom-built, rat-sized quadrature dual-tuned birdcage coil
resonant at both the 1H Larmor frequency and 13C Larmor frequency. The birdcage coil was
used to transmit/receive signal for 1H MRI and to transmit 13C signal only. The 13C surface
coil was used to receive signal for 13C MRSI. This TORO setup for reception of 13C-signal
enhanced the

13

C-SNR by up to 4 times and is discussed in more detail in Appendix A-1.

Heart rate (320-360 beats per minute), breathing rate (40-60 breaths per minute) and core
body temperature (37.0-37.8 °C) were monitored during the entire MRI experiment (Small
Animal Instruments Inc., Stony Brook, NY).
1

H MRI: A gradient echo pulse sequence was used to acquire T1 -weighted 1H images of the

rat thorax in the coronal and axial planes. The imaging parameters were as follows: FOV =
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12 cm × 12 cm, matrix = 128×128, TE = 2 ms and TR = 34 ms, flip angle = 30 degree, slice
thickness = 3 mm. These images were used to localize the

13

C data acquisition volume of

interest in the lungs as the boundary of the lungs was well visualized as a signal void
compared to the other tissues (e.g. heart and liver).
13

C MRSI: MRSI was performed using a CSI technique described previously.(39) An axial

FOV of 6 cm × 6 cm was chosen centred on the lungs, avoiding liver and large regions of the
heart. A 12 × 12 matrix was prescribed in the FOV with a slice thickness of 8 mm. CSI data
were acquired using a pulse-acquire approach (flip angle of 10 degrees, bandwidth of 5 kHz
and 256 points) with a repetition time of 80 ms for a total scan time of approximately 12
seconds. Spectroscopic imaging was initiated following a delay of 25 seconds from the start
of the bolus injection to maximize the lactate signal. The optimum lactate window was based
on previous 13C dynamic spectroscopy experience with a similar RILI rat model. (39)
MR data processing and analysis: SAGE™ software (GEHC, Waukesha, WI) was used for
processing and visualization of the

13

C data overlaid on 1H localization images. The

13

C

spectroscopic imaging data were apodized with a 10 Hz Gaussian filter in the time domain,
zero-filled 1× in the time dimension and both spatial dimensions. Fourier transformations
were then performed in both the time domain and the two spatial dimensions to obtain a 16 ×
16 grid of spectra with each voxel dimension of 3.75 mm × 3.75 mm × 8 mm. The metabolite
peaks were phased and baseline corrected for every voxel. The 16 × 16 grid of spectra was
overlaid on the axial 1H image and twelve voxels were chosen: four centred on the left lung,
four on the right lung and four on the heart. The relative positions of these four voxels for
each organ were kept consistent for each animal. The measure of lac/pyr for each group of
four voxels was computed by dividing the total lactate signal intensity in the four voxels by
the total pyruvate signal intensity in the four voxels, obtained by summing the appropriate
integrated metabolite peak in each voxel. Two-tailed, paired T-tests were performed for the
lac/pyr measurements corresponding to the left lung, the right lung and the heart between the
irradiated cohort and the healthy cohort for each time point. A p-value of less than 0.05 was
considered significant. A mixed analysis of variance with repeated measures at each time
point was also run on the data to determine any within- or between-subject interactions using
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SPSS software. (IBM, Markham, Ontario). Appendix A-2 contains more details on the twotailed paired T-test and mixed analysis of variance including the underlying assumptions.

3.2.5

Histology Preparation and Analysis

Following MRI, the rats were euthanized using an injection of 540 mg/kg rat mass of
sodium pentobarbital (Euthanyl Forte, Bimeda-MTC, Cambridge, Canada) and the lungs
extracted for histological analysis. The lungs were fixed by intratracheal infusion of 8 mL of
10% neutral-buffered formalin. The fixed lungs specimens were embedded in paraffin, cut
into 5 µm thick tissue sections and stained with H&E. Using a Zeiss Axio Imager microscope
(Toronto, Ontario, Canada), five representative images, at a magnification of 40 times and a
FOV of 240 µm by 320 µm, of the caudal lobe of right lung and from the basal left lobe were
taken using a Retiga EXi Digital CCD camera (Q imaging, Vancouver, BC, Canada) attached
to the microscope. Areas selected contained predominantly alveolar duct and alveoli,
avoiding any major airways and blood vessels. The infiltrating macrophages were counted
manually in each image to obtain macrophage density and were used as a gauge for injury
during RP. The criteria for counting macrophages were consistent for all images and were
defined as larger cells with clear boundaries and darker cytoplasm. Figure 3-2 shows a
representative H&E stained section of the right lung at day 25 for both a healthy and an
irradiated rat with the macrophages marked by black arrows.
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Figure 3-2: Section of H&E slide from lower right lung of a healthy (unirradiated) rat at day
25 (a) and from lower right lung of an irradiated rat at day 25 post-irradiation (b). There is a
clear increase in the number and size of macrophages as marked by the black arrows in the
irradiated lungs compared to the unirradiated lungs.

3.3 Results
Figure 3-3 shows a typical CSI grid overlaid on the corresponding 1H image for a
representative RILI rat, including the voxels chosen for analysis of lac/pyr in left lung, right
lung and heart region respectively. Figure 3-4 provides a summary of the average lac/pyr
measurements obtained from these regions in both the irradiated and healthy cohorts at day 5,
10, 15 and 25-post irradiation. Both the right lung and the left lung from the irradiated cohort
show a statistically significant increase in lac/pyr compared to the right lung and left lung
from the healthy cohort respectively at each time point. This confirms the response to
radiation both at the site of the irradiation (radiation therapy to medial right lung) as well as
the unirradiated (i.e. contralateral) left lung. The enhanced lac/pyr in the contralateral lung
was evident at all four time points and did not vary substantially from one time point to
another. Elevated lac/pyr in the right lung of irradiated cohort was consistent across all time
points.
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Figure 3-3: 13C MRSI overlaid on T1-weighted 1H axial image. The lung boundary is clearly
visualized by as signal void. 13C measurements were made in twelve voxels, four each from
the left lung, right lung and the heart region are indicated as a), b) and c) respectively. Voxel
positions with respect to the 1H image were kept consistent for all animals.
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Figure 3-4: Measurement of lac/pyr plotted for the right lung, left lung and heart regions in
the healthy and irradiated cohorts at all four time points post irradiation. Statistically
significant increases in lac/pyr (** p < 0.01, * p < 0.05) are apparent in the right lung and left
lung of the irradiated cohort compared to right lung and left lung of the healthy cohort or the
heart region at all time points post irradiation.
Additionally, mixed analysis of variance demonstrated a statistically significant decrease in
lac/pyr at day 25-post irradiation in the right lung of irradiated cohort compared to lac/pyr at
day 10-post irradiation in the right lung of the irradiated cohort (p < 0.05), suggesting the
initial phase of radiation induced effects beginning to subside. Table 3-1 summarizes lac/pyr
(mean ± first standard deviation) from the right lung, left lung and heart for irradiated and
healthy cohort for all time points.

76

lac/pyr

Macrophage count

Day 5

Day 10

Day 15

Day 25

Day 5

Day 10

Day 15

Day 25

Irradiated

0.37 ±

0.39 ±

0.37 ±

0.33 ±

18.13

14.80 ±

14 ±

13.80 ±

cohort right

0.04

0.02

0.02

0.02

± 1.53

1.70

1.41

2.26

Healthy

0.17 ±

0.26 ±

0.24 ±

0.21 ±

7.40 ±

9.33 ±

7.53 ±

6.80 ±

cohort right

0.06

0.06

0.03

0.03

1.56

3.39

1.15

0.35

Irradiated

0.39 ±

0.38 ±

0.41 ±

0.35 ±

15.47

14.60 ±

14.13 ±

13.33 ±

cohort left

0.04

0.07

0.08

0.03

± 1.81

1.13

1.50

1.70

Healthy

0.17 ±

0.22 ±

0.21 ±

0.20 ±

7.13 ±

9.30 ±

8.07 ±

6.47 ±

cohort left

0.05

0.04

0.07

0.01

1.50

3.25

1.45

0.76

Irradiated

0.22 ±

0.21 ±

0.25 ±

0.21 ±

cohort heart

0.04

0.03

0.04

0.01

Healthy

0.18 ±

0.24 ±

0.28 ±

0.25 ±

cohort heart

0.01

0.05

0.08

0.01

lung (n = 3)

lung (n = 3)

lung (n = 3)

lung (n = 3)

(n = 3)

(n = 3)

Table 3-1: Summary of lac/pyr from the right lung, left lung and heart regions and
macrophage count from right lung and left lung of the irradiated and healthy cohorts at each
time point post conformal radiation therapy. Data is represented as mean ± standard
deviation.
Measured lac/pyr was not statistically significant higher in the heart region of the irradiated
cohort compared to the heart region of healthy cohort at day 5, 10 and 15-post irradiation. At
day 25, lac/pyr was lower in the heart region of the irradiated cohort than the heart region of
the healthy cohort (0.21 ± 0.01 vs. 0.25 ± 0.01, n = 3, p < 0.05). Analysis of the histology
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from the heart region at day 10 and day 15-post irradiation confirmed that they did not show
any signs of injury.
Analysis of blood lactate concentration levels did not show statistically significant changes
between the irradiated and healthy cohorts at any time point post irradiation. Measurement of
blood lactate from all irradiated and healthy cohorts (non time point specific) was 1.22 ± 0.3
mM (n = 12) and 1.23 ± 0.31 mM (n = 12) respectively. Additionally, blood paO2 level
measurement for all irradiated and healthy cohorts (non time point specific) was 80 ± 15
mmHg (n = 12) and 78 ± 14 mmHg (n = 12) respectively. paO2 did not drop below normal
(60 mmHg) for any irradiated cohorts and there was a lack of a statistically significant
change in paO2 level between irradiated cohorts and healthy cohorts at any time point post
irradiation.
Table 3-1 summarizes the macrophage count for right lung and left lung from irradiated and
healthy cohorts at each time point. Figure 3-5 shows the time courses for average lac/pyr and
macrophage count for all time points for both the right and left lung of both cohorts.
Macrophage counts were observed to increase in both the left and right lung of the irradiated
cohort compared to the healthy cohort, following a trend similar to lac/pyr at each time point.
Figure 3-6 shows a scatter plot of the lac/pyr measurements versus macrophage count for the
right and left lung of all the rats for all time points. Non-parametric analysis of these data
provided Spearman coefficients (r) of 0.86 (p < 0.01) and 0.85 (p < 0.01) respectively for the
right and left lung. The strong correlation between lac/pyr and macrophage count suggests
that the enhanced lac/pyr seen in the irradiated cohort is likely due to inflammation
associated with RP, potentially up-regulation of macrophage activity.
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Figure 3-5: Time evolution of the average lac/pyr in healthy and irradiated cohorts in the
right lung (a) and left lung (b) for the healthy and irradiated cohorts. The corresponding
macrophage counts are shown in (c) and (d). A similar time trend can be seen for both lac/pyr
and macrophage count.
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Figure 3-6: Scatter plot of lac/pyr versus macrophage count in right lung (a) and left lung (b)
for all rats showing strong correlation in both the right lung (r = 0.86, p < 0.01) and the left
lung (r=0.85, p < 0.01) respectively.

3.4 Discussion
To our knowledge this is the first time that hyperpolarized 13C-pyruvate MRSI has been used
to assess the early phases of RILI longitudinally following conformal radiation therapy,
specifically RP. In this rat model of RILI involving conformal irradiation of the right lung,
measures of lac/pyr were shown to be elevated in both right and left lung at all time points (5,
10, 15 and 25 days) following irradiation. This is consistent with previous observations in a
similar rat model, which showed that cytokines and DNA damage persist 5 to 15 days and 3
days to 4 weeks post irradiation respectively. (25) The statistically significant decrease in
lac/pyr in the right irradiated lung observed at day 25 compared to day 10 may be evidence
of reduced inflammation from the receding initial phase of RP. This seems to be supported
by the reduction in measured macrophage activity at the later time points (Figure 3-5).
Additionally, lac/pyr was also shown to detect the response of the entire lungs to conformal
radiation therapy (medial right lung) both at the site of irradiation but also on the unirradiated
contralateral side (left lung). This observation is in agreement with previous findings, which
have demonstrated that conformal radiation therapy of the lungs results in injury response of
the lungs both in and out of the radiation field (21, 22).
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Measurements of lac/pyr did not show altered heart metabolism at any time point. This was
confirmed by the analysis of the histology from the heart region. Analysis of the lactate
concentration and paO2 levels of the blood also showed no statistically significant difference
between the healthy and irradiated cohorts for any time points. Lack of change in both
lac/pyr in the heart region and in blood lactate levels between the two cohorts demonstrates
that the injury response was only in the lungs with no systemic effects. This confirms that the
irradiation conformed to the right lung, sparing other surrounding tissues. As expected, this
was not seen in our previous studies involving whole-thorax irradiation, which resulted in a
significant increase in lac/pyr in the heart tissue and increases in blood lactate levels at 2
weeks post-irradiation. (39)
The lack of a paO2 decrease (below 60 mmHg) in any of the rats at any time point and the
lack of a statistically significant change in paO2 level between healthy and irradiated cohorts
confirms the response to radiation was confined to the lungs. Unlike our previous finding of
decreased paO2 in the blood following whole thorax irradiation (41), the conformal
irradiation of the right lung does not appear to compromise the lung function and could be
attributed to the compensatory effects of the unirradiated lung, enabling adequate oxygen
supply to the body. In addition to the conformal radiation therapy, the lower dose rate of the
radiation beam used in this study may also have reduced the level of tissue injury.
Figure 3-5 shows that the macrophage count in both the left and right lung of the irradiated
cohort was higher than the corresponding left and right lung of the healthy cohort. Previous
studies have shown that macrophages are recruited from outside the radiation field post
irradiation (19) and that these infiltrating macrophages are a source of cytokines associated
with onset of inflammation in early RP. (20) As such, macrophage count is a useful
quantitative indicator of the inflammation in early RILI. Additionally, the error bars (single
standard deviation) on macrophage count as shown in Figure 3-5 c) and d) do not overlap
between the healthy and irradiated cohort at any time point in either the left lung or the right
lung. This trend is similar to lac/pyr trends observed in the healthy and irradiated cohorts
(Figure 3-5 a) and b)). The hypothesis that lac/pyr changes may be a reflection of increased
macrophage activity associated with RP is further supported by the strong correlation
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between macrophage count and lac/pyr for the right lung (r = 0.86, p < 0.01) and the left lung
(r = 0.85, p < 0.01). This hypothesis also seems to be supported by previous evidence linking
increases in lac/pyr with inflammation in other disease (arthritis) models. (44) Increasing the
sample size (n > 3) should result in more powerful statistics and better quantification of
lac/pyr and macrophage count to further support this hypothesis. Staining for particular
macrophage type and following the evolution of type II pneumocyte population post
irradiation could provide further insight into the progression of RILI.
In summary, early metabolic changes (over days) can be mapped using hyperpolarized 13Cpyruvate MRSI in a rat model of RILI using conformal radiation therapy. Specifically,
lac/pyr is observed to increase in irradiated and unirradiated lung regions consistent with
histological changes associated with radiation pneumonitis. Increases in lac/pyr are highly
correlated with macrophage count in both the irradiated and unirradiated lung suggesting that
part of the enhanced lac/pyr may be caused by an increase in the number and activity of
resident and infiltrating inflammatory macrophages. Future studies could focus on the use of
hyperpolarized

13

C-pyruvate MRSI to measure the effects on radiation pneumonitis arising

from varying conformal radiation therapy (dose, dose rate, fractionation scheme etc.) and
intervention during the course of the injury for mitigation of RILI. Furthermore, application
of this technique in a clinical environment should also be possible with the recent availability
of hyperpolarized 13C-pyruvate for human use.
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Chapter 4: Rapid and Accurate Mapping of pH using
Spiral-IDEAL with Hyperpolarized 13C-bicarbonate

K. Thind, C. N. Wiens, A. P. Chen, H. Lim, P. Martinez, A. Ouriadov, C.A. McKenzie, T. J.
Scholl, R. F. Schulte, G. E. Santyr
An updated version of the following chapter will be submitted to Magnetic Resonance in
Medicine as a Technical Note.

4.1 Introduction
Many fundamental physiological mechanisms in the human body depend on pH balance,
thereby making pH regulation one of the most important homeostatic processes (1). Two
major endogenous buffers that regulate pH are the phosphate buffer and the bicarbonate
buffer. Specifically, the bicarbonate buffer is responsible for 86% of the extracellular
buffering capacity. (2) Physiologically stable pH is measured at 7.35 – 7.45 for the human
body. (3) Disruption of pH balance, local or systemic can result from a variety of disorders
such as cancer, metabolic acidosis, chronic respiratory acidosis, stroke, cardiac failure,
inflammation and infection. These disorders cause major changes in physiology such as
altered energy metabolism, perfusion changes, failure of Na+/H+ transporters and lower lung
tidal volumes (4). As a result of these changes, enhanced anaerobic glucose metabolism leads
to accumulation of lactic acid and in combination with poor perfusion and reduced
bicarbonate buffering capacity, lead to an acidic extracellular pH (pHe) (5). Although
measurement of blood pH using an electrophysiological probe can indicate a systemic
problem, it cannot point to the local site of the disorder (4). Furthermore, as metabolic
changes precede functional and anatomical changes, it is important that spatially-localized
changes in pHe be mapped in diseases to improve sensitivity, for example in cancer, where
pHe change is linked strongly to prognosis and outcome (4). Significantly lower pHe (~6.7)
in the tumour microenvironment has been reported in the literature. (6)
Several MRI and MRS techniques have been used to map pH using both exogenous
substances and endogenous compounds. 31P-MRS has been used to estimate intracellular pH
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(pHi) using endogenous inorganic phosphate (5). Exogenous 19F compounds have been used
to quantify pH in vivo using

19

F-MRS. A fluorinated derivative of vitamin B6, 6-

fluoropyridoxol has been shown to measure both pHe and pHi in rodent tumours (7). A major
drawback of this technique is the instability of the fluorinated compounds. Exogenous
substances such as Imidazole with pH sensitive 1H resonances have been used to quantify
pHe with the aid of 1H-MRS (8, 9). However, the rather small chemical shift (0.7 ppm) over
the entire titration range makes this technique less viable at lower field strengths. The 1HMRI magnetization transfer technique referred to as Chemical Exchange Saturation Transfer
(CEST) has also been used to measure pHi based on endogenous amide groups in mouse
brain under ischemia and with gliomas (10, 11). A more specific CEST technique has been
used with exogenous substrates such as 5,6-dihydrouacil to measure pHi as well (12).
Limitations to CEST techniques include high concentration requirement for the CEST agent
and the need for strong MRI radiofrequency (RF) pulses in order to enhance the saturation
effect. Similar to CEST, pH dependent relaxation agents such as Gd(DOTA)-4AmP5- have
been used to measure renal pHe (13) but are highly dependent on favourable
pharmacokinetics. Overall, the above MRI methods are limited by inherently low signal-tonoise ratio (SNR).
One of the more recent pHe measurement techniques utilizes hyperpolarized 13C-bicarbonate
and Chemical Shift Imaging (CSI) approaches. With advances in Dynamic Nuclear
Polarization (DNP), polarization of

13

C-substrates can be enhanced by up to 100,000 times

compared to thermal polarization (14). In vivo, the carbonic anhydrase (CA) enzyme
facilitates equilibration between bicarbonate and carbon dioxide (equation [37]):
!
𝐻𝐶𝑂!
! +   𝐻   

𝐶𝐴

  𝐶𝑂! + 𝐻! 0

[37]

Gallagher et al. have used the CSI method to quantify in vivo pHe in a mouse tumour model
using hyperpolarized

13

C-bicarbonate (H13CO3-) and its metabolite

13

C-carbon dioxide

(13CO2) via the Henderson-Hasselbalch equation (15), based on equation [37]:

pH  =  pKa  +  log10  ([H13CO3-‐]/[13CO2])
where H13CO3- and

13

[38]

CO2 are the signal intensities obtained from the in vivo spectra.

Unfortunately, CSI is time-consuming (several minutes) and not the most efficient way to use
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the available non-renewable hyperpolarized magnetization. CSI utilizes a large number of RF
pulses (typically equal to the number of voxels), acquires a coarse spatial resolution (16 x 16)
and takes a considerable amount of time (~12 s) to acquire the entire scan, thereby limiting
SNR due mainly to the short T1 relaxation time of the
metabolite

13

13

C-bicarbonate (~10 s) and its

C-carbon dioxide (~10 s) in vivo. Spatial encoding with CSI can be

accomplished more quickly using echo-planar read-out approaches (16, 17) and spiral readout approaches (18, 19). However, echo-planar and spiral CSI still suffer from coarse spatial
resolution and long acquisition times (e.g. a 12 × 8 × 16 spatial encoding takes 15.4 s) when
suitable spectral resolution is required for substrates such

13

C-pyruvate and its many

downstream metabolic products (17)
As the 13C-bicarbonate and 13C-carbon dioxide spectrum is sparse in nature (ie. two peaks),
the spectral resolution may be traded off for improved spatial resolution. The Dixon approach
has proven to be useful to image sparse spectra as it exploits prior information of the
chemical shifts between sparse chemical peaks in a spectrum to optimize readout echo
spacing for improved efficiency. With this method, n+1 echoes from a sparse spectrum
containing n substrate peaks can be used to resolve the spatial distribution of each of the
substrates as well as account for B0 field non-uniformities in the volume of interest. A Dixon
approach-incorporating IDEAL has been used extensively to separate fat and water images in
1

H-MRI (20-23). Spiral-IDEAL single shot images with echo time shifts in between

excitations has been used to encode the spectral-spatial concentration of hyperpolarized 13Cpyruvate and its metabolites (24). With this technique, k-space is encoded in an outward
spiral fashion following a single excitation RF pulse, which helps preserve the nonrenewable polarization of 13C-metabolites.
The purpose of this work was to implement a spiral-IDEAL method to map pH utilizing
hyperpolarized 13C-bicarbonate. Initial validation of the method was performed in thermallypolarized phantoms by comparing pH measurements using spiral-IDEAL with pH
measurements obtained using a conventional single-voxel FID-CSI approach. Both above
MRI methods were compared with measurements obtained using a pH meter. The spiralIDEAL technique was then used to map pH with hyperpolarized
metabolic by-product

13

13

C-bicarbonate and its

C-carbon dioxide in vitro. Extension of this technique to in vivo

applications is discussed.
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4.2 Methods
4.2.1

Construction of Thermally-Polarized Phantoms

Five phantoms with pH ranging from 7.02 to 7.96 were constructed for in vitro validation of
the spiral-IDEAL approach. 1 g of

13

C-sodium bicarbonate (Sigma-Aldrich, Oakville, ON,

CA) was dissolved in 20 ml of deionized H2O. 200 µl ProHance (Bracco Imaging, Anjou,
QC, CA) was added to the resulting mixture to yield a T1 of 54 ms to improve polarization.
The mixture was then divided into five equal 4 mL volumes and placed in five 8 ml glass
vials. An appropriate volume of 1 N HCl was added to adjust the pH of each vial. The
mixtures were sealed and stored for two weeks to ensure equilibration of H13CO3- and 13CO2.
The pH of each mixture was verified by measurement using a standard pH meter
(sympHony, VWR, Mississauga, ON, CA).

4.2.2

FID-CSI and Spiral-IDEAL pH Mapping

FID-CSI and spiral-IDEAL were performed using a 3T MRI system (MR750, GEHC,
Waukesha, WI, USA) equipped with multinuclear hardware and software. FID-CSI and
spiral-IDEAL acquisitions were performed on each thermally-polarized phantom
independently using a solenoid

13

C coil resonant at a frequency of 32.12 MHz. Imaging

parameters for the FID-CSI acquisition were as follows: Gaussian pulse, FOV of 12 × 12 cm,
TR of 1 s, bandwidth of 5 kHz, number of points equal to 2048, flip angle of 90 degree,
matrix size 1 × 1, number of RF pulses equal to 512, giving a total scan time equal to 8 min
and 32 s. (total number of scans equal to 512 as one FID per scan) The spiral-IDEAL
sequence acquires a FID prior to acquisition of the echoes, which aids in reconstruction of
the spectral information. More details on the spiral-IDEAL sequence can be found in
Wiesinger et al. (24) Each excitation pulse is followed by a single-shot outward spiral readout. The echoes are time shifted from excitation to excitation to encode the spectral
information. Based on the three echoes and a frequency shift between
13

13

C-biarbonate and

C-carbon dioxide of 36 ppm, an echo time shift of 292 µs was determined to yield

maximum SNR, which was used in the acquisition. A FID was also acquired prior to the
echoes in every scan, which aids in the reconstruction. The following additional parameters
were used: FOV of 12 × 12 cm, TR of 250 ms, flip angle of 90 degrees, echo time shift of
292 µs, number of RF pulses equal to 256, giving a total scan time equal to 1 min and 4 s.
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(total number of scans equal to 64 as one FID and three echoes per scan)

4.2.3

Data Processing

FID-CSI data were processed using SAGETM software (GEHC, Waukesha, WI, USA).
H13CO3- and 13CO2 peaks were established to be ~36 ppm apart. A spectral apodization of 5
Hz was used. Peak areas for H13CO3- and

13

CO2 were calculated for each vial and the ratio

was used to compute pH using the Henderson-Hasselbalch equation (equation [38]). The pKa
was assumed to be 6.17 (15). For spiral-IDEAL, the spectral information in the FID was used
in the reconstruction of metabolite images. The acquired k-space data were filtered and an
image-encoding matrix of 128 × 128 was calculated based on the spiral-readout (24). The
spiral-IDEAL reconstructed metabolite images were further processed off-line using Matlab
(MathWorks, Natick, MA) to obtain the pH maps. A spectral apodization of 15 Hz was
performed and a pixel-by-pixel ratio of H13CO3- and 13CO2 intensities was used to compute a
map of pH using equation [38] with an assumed pKa of 6.17. To reduce noise in the pH map,
only those voxels with a signal greater than three times the standard deviation of background
noise in the 13CO2 image were used in the 13CO2 image. Corresponding pixels in the H13CO3image were used to compute the final pH map.

4.2.4
13

Hyperpolarized 13C-bicarbonate Preparation and Polarization

C-sodium bicarbonate was hyperpolarized using a commercially available DNP system

(Hypersense, Oxford Instruments, UK). The

13

C-sodium bicarbonate (Sigma-Aldrich,

Oakville, Canada) was initially dissolved in glycerol to yield a concentration of 1.7 M using
a magnetic stirrer and hot plate (70 °C) and 18 mM trityl radical (OX63, Oxford Instruments,
UK) was added to the mixture (25). To get the final dissolution, 5 ml of phosphate buffer
dissolution media with a pH of 7.4 was used to dissolve a 170 µl hyperpolarized sample for a
final concentration of 58 mM

13

C-sodium bicarbonate. The absolute

13

C-bicarbonate

polarization available following DNP at 3T was measured to be between 2-4%.

4.2.5

In Vitro pH Mapping using Hyperpolarized 13C-bicarbonate

Immediately following the dissolution, equal amounts of hyperpolarized

13

C-bicarbonate

were mixed with two 4 ml 500 mM sodium phosphate-buffered solutions at pH 6.83 and 7.19
(measured using the pH meter) respectively containing 10ug of CA enzyme (Isozyme II from
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bovine erythrocytes, 3000W-A units/mg protein, Sigma Aldrige St. Louis, MO, USA). The
spiral-IDEAL acquisition was initiated following a delay time of 5 s to allow the H13CO3and

13

CO2 to equilibrate. The spiral-IDEAL acquisition was setup with the following

parameters: field of view of 12 × 12 cm, repetition time of 250 ms, three echoes spaced 292
µs apart, flip angle of 20 degrees, number of RF pulses equal to 100 and total scan time equal
to 25 s. (total number of scans equal to 25 as one FID and three echoes per scan) Data
processing was performed in an identical fashion as described above for the spiral-IDEAL
imaging of the thermally-polarized phantoms.

4.3 Results
Figure 4-1 presents a typical thermally-polarized phantom spectrum showing H13CO3- and
13

CO2 peaks separated by 36 ppm which was obtained using the FID-CSI method. Using

equation [38], pH was computed to be 7.48. Using a standard pH meter, the pH for the same
solution was measured to be 7.46. The agreement between FID-CSI and actual pH was
measured for a range of pH values from 7.03 and 7.98 as listed in Table 1. The difference
between pH measurement by the FID-CSI method and the pH meter ranged from 0.27 to 2.26
%.
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13

-

A. U.

H CO3

13

CO2

Frequency (ppm)
Figure 4-1: Spectrum obtained from FID-CSI of the vial with pH meter measurement of 7.46
(FOV 12 cm, TR 1s, BW 5k, 2048 pts, 512 averages). pH calculated from above spectrum
based on the ratio of peak areas of H13CO3- and 13CO2 using the Henderson-Hasselbalch
equation was 7.48 (equation [38]). All pH measurements using FID-CSI method are listed
and compared with standard pH meter measurements in Table 4-1.

93

pH = 7.03
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Figure 4-2: Cross section pH map of the vials acquired using IDEAL (FOV 12 cm, TR 250
ms). Mean pH of the vials ranges from 7.03 to 7.98 which all fall within < 0.5 % of the actual
pH (using a pH meter). Standard deviation in the spiral-IDEAL pH measurements ranges
from 0.41 for pH of 7.03 to 0.89 for pH of 7.99, as reported in Table 4-1.
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pH meter
(actual pH)

FID-CSI pH
measurement

Difference
from actual

Spiral-IDEAL pH
measurement (mean ± 1

Difference
st

from actual

std. dev. in pH map)
7.02

7.08

0.86 %

7.03 ± 0.41

0.14 %

7.31

7.34

0.41 %

7.30 ± 0.54

-0.14 %

7.46

7.48

0.27 %

7.45 ± 0.79

-0.13 %

7.67

7.72

0.52 %

7.68 ± 0.60

0.13 %

7.96

8.14

2.26 %

7.99 ± 0.89

0.38 %

mean

0.86 %

mean

0.08 %

std. dev.

0.81 %

std. dev.

0.22 %

Table 4-1: pH measured using the pH meter, spiral-IDEAL method and FID-CSI methods
along with differences are displayed in the columns respectively. Mean and standard
deviation of the difference in pH between MRI methods and pH meter are shown at the
bottom.
Figure 4-2 shows the pH maps derived using spiral-IDEAL acquisitions of the five vials.
Quantified mean and standard deviation of pH from the spiral-IDEAL pH maps for each vial
are listed and compared to the standard pH meter reading in Table 1. The difference between
mean pH measurement by the spiral-IDEAL method and the pH meter ranged from -0.14 to
0.38 %. The standard deviation of the pH maps obtained using spiral-IDEAL range from 0.41
for low pH (7.02) to 0.89 for high pH (7.96).
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8.3

Spiral IDEAL datapoints
FID-CSI datapoints

pH measured using MR methods

8.1
7.9
7.7
7.5
7.3
7.1
6.9
6.9

7.1
7.3
7.5
7.7
7.9
pH measured using standard pH meter

8.1

Figure 4-3: Linear regression fits between pH measured using pH meter on horizontal axis
and FID-CSI method on vertical axis (y = 1.009x, R2 = 0.9765) and between pH measured
using pH meter on horizontal axis and spiral-IDEAL method on vertical axis (y = 0.9917x,
R2 = 0.9830).
Figure 4-3 demonstrates pH measurement with the pH meter on the horizontal axis and pH
measurement with the MRI methods on the vertical axis. The standard deviation of the pH in
the spiral-IDEAL pH maps is plotted as the error bars. A strong agreement between pH
measured using the FID-CSI method and the pH meter as well as pH measured using spiralIDEAL and the pH meter is observed. A linear regression fit between pH measurement using
pH meter and FID-CSI method (y = 1.009x, R2 = 0.9765) appears to be similar compared to
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the linear regression fit between pH measured using the pH meter and the spiral-IDEAL
approach (y = 0.9917x, R2 = 0.9830).
Figure 4-4 presents the in vitro pH maps obtained using spiral-IDEAL with hyperpolarized
13

C-bicarbonate. Spiral-IDEAL pH measurements of 6.82 ± 0.21 and 7.16 ± 0.25 (mean ±

first standard deviation in pH map) compared well to pH meter readings of 6.83 and 7.19
respectively. The high standard deviation of the hyperpolarized pH maps may be attributable
to the low polarization level of 13C-bicarbonate that translates to a low 13CO2 SNR.

8.0

pH	
  =	
  6.82	
  

pH	
  =	
  7.16	
  

7.5
7.0
6.5
6.0
5.5

Figure 4-4: In vitro pH mapping with hyperpolarized 13C-bicarbonate using the spiralIDEAL method. Carbonic anhydrase enzyme was added to the phosphate buffer solutions for
rapid conversion and equilibration of hyperpolarized 13C-bicarbonate to 13C-carbon dioxide.
Spiral-IDEAL pH measurements of 6.82 ± 0.21 and 7.16 ± 0.25 (mean ± first standard
deviation in pH map) compared well to pH meter readings of 6.83 and 7.19 respectively.

4.4 Discussion
The conventional CSI method has been demonstrated in the literature to measure pH using
hyperpolarized

13

C-bicarbonate (15). This was verified here by comparison of the pH

measurement using the FID-CSI method and a standard pH meter. In this work, a spiralIDEAL approach was used based on the known chemical shifts and sparse (i.e. two peak)
spectrum associated with 13C-bicarbonate to rapidly form (8 times faster than CSI) metabolite
maps (24). This method was then used to form images of H13CO3- and

13

CO2 in thermally-
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polarized phantoms, which were then used in conjunction with the Henderson-Hasselbalch
equation to compute pH maps (equation [38]). Validation of this method as a tool for
accurate pH measurement was performed using a standard pH meter, where a strong linear
regression fit between pH measurement using spiral-IDEAL and standard pH meter
demonstrated the accuracy of this method (Figure 4-3).
The pH in each thermally-polarized phantom was independently measured by FID-CSI,
spiral-IDEAL and a pH meter. The scan time for the FID-CSI is proportional to the number
of RF pulses used, which in turn is proportional to the matrix size used in the acquisition.
Spiral-IDEAL presents a distinct advantage with the single-shot readout such that the number
of RF pulses does not increase with the matrix size. For example, if the FID-CSI approach
used an 8 x 8 matrix, the total scan time would have been 64 times as much as it has been
reported. In comparison, the spiral-IDEAL inherently performs pH mapping with a matrix
size of 128 x 128 with the reported scan time. Additionally, use of FID-CSI with
hyperpolarized 13C-bicarbonate and a large matrix size would reduce SNR due to the smaller
voxel and significant T1 decay of hyperpolarized 13C-bicarbonate and 13C-carbon dioxide due
to the longer scan time.
It should be noted that both CSI and spiral-IDEAL techniques are highly sensitive to the
concentration of
13

13

CO2 relative to H13CO3-. As absolute pH increases, the concentration of

CO2 decreases, thereby decreasing 13CO2 SNR. This introduces a potential for larger error

at higher absolute pH compared to lower absolute pH. This phenomenon is observed in Table
1 where standard deviation of pH was reported for the spiral-IDEAL measurement as an
estimate of the error in the pH maps. The error was smaller (0.41%) at lower pH (7.02) and
higher (0.89%) at higher pH (7.96). Additionally, larger differences from actual pH (pH
meter reading) for the MRI methods (FID-CSI and spiral-IDEAL) are observed for the vial
with a higher measured pH. The precision and accuracy of the pH maps obtained from spiralIDEAL would both likely benefit from a higher number of averages in the MRI acquisition
of each vial due to the associated increase in 13CO2 SNR.
In this study, an absolute polarization level of the hyperpolarized

13

C-bicarbonate at 3T

following DNP was between 2% and 4%. This was lower than anticipated and prohibited
implementation of the technique in vivo in the present study. A lower polarization results in

98

lower SNR for both

13

CO2 and H13CO3-, but the

13

CO2 SNR affects pH mapping more

profoundly as it is the lower concentration metabolite. In vitro hyperpolarized 13CO2 SNR for
the spiral-IDEAL pH map with a mean pH of 7.16 was approximately 2. Higher 13CO2 SNR
is required at higher pH as an increase in pH leads to reduction in the absolute concentration
of 13CO2, as dictated by equation [38]. A theoretical increase in in vitro pH from 7.16 to 7.4
would result in a two-fold increase in 13CO2 SNR thereby allowing improved image quality
as presented in Figure 4-4. Furthermore, in vivo use would result in a reduction in T1
relaxation time of the

13

CO2 in addition to a longer wait time before imaging following the

administration of hyperpolarized

13

C-bicarbonate. The longer wait time is required for the

lengthy intravenous injection (~10 s) as well as additional transit time for H13CO3- to move
into the extracurricular space (estimated 5-7 s). The T1 relaxation time of

13

CO2 was

estimated to reduce from ~30 s in vitro to ~10 s in vivo. We estimate an in vitro 13CO2 SNR
of ~10 with our current imaging parameters to be sufficient for a suitable in vivo pH map.
Keeping everything else consistent, this requires a

13

C-bicarbonate polarization level of 10-

20%, which has been achieved by others. (26)
In summary, rapid and accurate pH mapping was demonstrated in phantoms using
hyperpolarized

13

C-bicarbonate with the spiral-IDEAL technique. Comparison of the pH

measurement using the spiral-IDEAL technique and FID-CSI method as well as the spiralIDEAL method and a standard pH meter provide validation for the applicability of this
method. Accurate in vitro pH mapping with hyperpolarized 13C-bicarbonate provides further
evidence for the usability of this technique. Application of this technique in vivo may be
possible with the new DNP polarizers that promise higher polarization of 13C-substrates and
improved bicarbonate preparations (e.g. Cesium 13C-bicarbonate). (15)
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Chapter 5: Discussion and Future Work
In this work, new approaches to quantify in vivo metabolism using hyperpolarized
substrates (13C-pyruvate and

13

13

C-

C-bicarbonate) have been investigated. These two substrates

were polarized to a high degree (~10,000-100,000 ppm) for the feasibility of in vivo imaging
at a magnetic field strength of 3T. The higher polarization was required to compensate for the
lower gyromagnetic ratio (about ¼ of 1H gyromagnetic ratio – Table 1-2) and lower
concentration of the 13C-substrates compared to 1H. The gyromagnetic ratio of 13C-substrates
dictated the thermal polarization of ~2.5 ppm compared to a thermal polarization of ~10 ppm
for 1H at a magnetic field strength of 3T. Additionally, the higher polarization compensated
for the lower concentration of

13

C-substrates (80 mM for

13

C-pyruvate and 60 mM for

13

C-

bicarbonate) administered intravenously compared to the concentration of water in vivo
(estimated at 55 M). In vivo metabolism was quantitated regionally by measuring the ratio of
lac/pyr following injection of hyperpolarized

13

C-pyruvate. In the first study (Chapter 2), a

higher lac/pyr was observed in rodent lungs and heart two weeks post-irradiation of the entire
thorax using a 60Co source (14 Gy, one fraction). Radiation Pneumonitis (RP) was confirmed
qualitatively by macrophage infiltration observed in cell micrographs from irradiated rodents.
Lack of increase in lac/pyr and lack of macrophage infiltration was observed in the agematched healthy cohort. This study was improved upon in Chapter 3 by performing
conformal radiation therapy, acquisition of regional and longitudinal lac/pyr data and
acquisition of quantitative histology. The conformal radiation therapy was delivered using a
modified uCT machine to the right rodent lung (18.5 Gy, two fractions). Regional (left lung,
right lung and heart) and longitudinal (day 5, 10, 15 and 25 post radiation therapy)
acquisition of lac/pyr demonstrated organ wide response of injury in the entire lung. Lack of
increase in lac/pyr in the heart region was observed. Infiltrating macrophages were counted
in the lower lung regions to obtain quantitative histology that confirmed an organ-wide
response to the irradiation (left and right lung) and a lack of injury to the heart region. In
Chapter 4, hyperpolarized

13

C-bicarbonate was used to map pH with the spiral-IDEAL

technique. As bicarbonate is the largest extracellular buffer in vivo, the ratio of bicarbonate to
its metabolic product of carbon dioxide provides an estimate of the pH. Validation of the
spiral-IDEAL technique was performed using thermal phantoms with pH varying from 7.02
to 7.96. The feasibility of this technique was further demonstrated by the use of
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hyperpolarized

13

C-bicarbonate to map pH in vitro with the aid of carbonic anhydrase

enzyme.

5.1 Radiation Pneumonitis Induced using 60Co
Chapter 2 describes the study performed to quantify lac/pyr in rodent lungs post-irradiation
of the whole thorax using

60

Co. Pilot experiments were initially performed to select a dose

that would induce RP in the rodent lungs. Two animals were irradiated in the whole thorax
(one fraction) with a dose of 12 Gy, 14 Gy and 18 Gy in each cohort for a total of 6 animals.
12 Gy was deemed to be too low and 18 Gy led to severe adverse symptoms (e.g. weight
loss, difficulty in breathing). The dose of 14 Gy was chosen to be adequate to induce RP
without inducing severe adverse symptoms.
Uniform irradiation to the rodent thorax was performed by providing 7 Gy of dose in the
supine position and 7 Gy of dose in the prone position for a total dose of 14 Gy. Collimation
of the

60

Co beam was accomplished using a lead block with a circular opening 4 cm in

diameter. Attempts to avoid irradiation to the liver region of the rodents were made by using
an animal positioning system. As such, direct exposure of the rodents’ liver to the irradiation
beam was avoided; although 60Co with its large geometric penumbra could have contributed
to some dose to the liver region. The thickness of the animal position system (0.75 cm) also
ensured a build-up region for the high-energy 60Co beam (1.2 MeV).
The timeline to perform imaging post-irradiation was based on a similar irradiation technique
in the literature. (1) Two weeks post-irradiation, higher lac/pyr was observed in the lungs and
the heart region of the irradiated cohort compared to the age-matched healthy cohort. The
injury was confirmed by macrophage infiltration observed in cell micrographs. A lower paO2
was also observed in the irradiated cohort compared to the healthy cohort. Irradiation of the
whole thorax was responsible for the higher lac/pyr in the heart region of the irradiated
cohort. Although the heart is less radiosensitive than the lungs, the irradiation of the whole
thorax led to a significant increase in the lac/pyr in the heart region. The parameter of lac/pyr
was also quantified for the kidneys to estimate systemic effect of the irradiation. Lack of
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increase in lac/pyr in the kidneys confirmed the localized response to irradiation was limited
to the thorax region, as measured by lac/pyr.
A birdcage 13C-RF coil and a surface 1H-RF coil were used to perform MRI and MRSI. The
surface coils are known for their high sensitivity but a lack of uniformity along the direction
orthogonal to the surface-plane of the coil. As such they lack B1 uniformity (i.e., intensity)
along the depth direction. This can be observed in Figure 2-6 as a gradient in the 1H image
that forms the background image underlaid below the
13

13

C-CSI data in Chapter 2. Although

C-RF coil was sufficient to obtain 13C-signal from lungs and the heart region, it lacked the

SNR needed to delineate

13

C-signal from the left and right lung. Nevertheless, this study

demonstrated the feasibility of hyperpolarized 13C-pyruvate to detect RP using lac/pyr. A few
areas of improvement that were addressed in the study in Chapter 3 included: a) conformal
radiation therapy, b) regional acquisition of lac/pyr (left and right lung) using a TORO coil
approach and, c) acquisition of quantitative histology.

5.2 Radiation Pneumonitis Induced using Conformal
Radiation Therapy
The study presented in Chapter 3 improved upon the findings in Chapter 2. In this study, 12
rodents were irradiated with two fractions of 9.25 Gy each given 24 hours apart in a
conformal fashion using a modified uCT system. (2) A higher dose than used in the previous
study (Chapter 2) was used to compensate for the low dose rate of the uCT system (~0.15
Gy/min) compared to the

60

Co (~1.1 Gy/min). (3) The

13

C-data was acquired from the left

lung, the right lung and the heart region of 3 irradiated rodents and 3 healthy age-matched
rodents each at day 5, 10, 15 and 25 post radiation therapy.
The irradiation was conformed to the right lung using two parallel-opposed beams with a
FOV of 14 mm x 14 mm. The energy output of the uCT machine was 140 kVp with a half
value layer of 6 mm of Aluminum. The procedure was also gated to the breathing cycle of
the rodents for accurate dose registration. This ensured minimal dose to the contralateral lung
as well as the heart and the liver region. The low energy of the uCT beam led to high dose
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deposition in the bones that were present in the irradiation field (ribs, part of spine) due to the
photoelectric effect.
The 13C-MRSI data was collecting using the TORO operation, which offered a significantly
higher SNR that allowed delineation of the 13C-data from the left lung and the right lung. The
TORO system allowed for rapid switching between the 1H-13C-birdcage transmit coil and a
13

C-surface receive coil for an SNR improvement of ~4 times over the 1H-13C-birdcage

transmit/receive coil for 13C-MRI. The construction, setup and enhancement using the TORO
operation are discussed in detail in Appendix A-1.
An increase in lac/pyr was observed both in the right lung (site of irradiation) and in the left
lung (contralateral lung) at all time points post-irradiation. A lack of increase in lac/pyr in the
heart region was also observed at all time points post-irradiation. Blood paO2 did not change
significantly between the irradiated and healthy cohorts at all time points post irradiation.
The high dose in the bones did not lead to any adverse effects or change the observed lac/pyr
in adjoining lung regions. Macrophages counts in the rodent lungs was significantly higher in
both left and right lungs of the irradiated cohorts compared to the healthy cohorts at all time
points. It is possible but not likely that the contralateral lung responded directly to the small
direct dose that it received during the irradiation procedure. The reason that it is unlikely is
due to the very small volume in addition to the very small dose (< 0.5 Gy) that the
contralateral lung received during the irradiation procedure, as demonstrated by the dose
distribution in Figure 3-1. (3)
The high correlation between the macrophage count and lac/pyr could potentially mean that
part of the enhanced lac/pyr may be attributable to the increase in metabolically-active
macrophages infiltrating the lung tissue. Further testing is required to verify the above
statement. Although the low dose rate of the uCT system did ensure RP in the rodent lungs, a
lack of fibrosis at 16 week post-irradiation was observed in the histology. This implied that
most of the injury had been repaired and that the healthy lung was restored. This
demonstrates that the lac/pyr parameter is quite sensitive to RP in the rodent lungs, as
confirmed by the histology. Therefore, a very high dose to ensure severe RP is not a
requirement for observation of the injury using lac/pyr. Nonetheless, a dose escalation study
would help understand the injury in a better manner.
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5.3 pH Mapping using 13C-bicarbonate with Spiral-IDEAL
The study presented in Chapter 4 presents a novel method to map pH using hyperpolarized
13

C-bicarbonate with spiral-IDEAL. The acid-base pair of bicarbonate and carbon dioxide

forms the largest extracellular buffer in the body. (4) The Henderson-Hasselbalch equation
can be used to compute the final pH of the bicarbonate-carbon dioxide pair. The spiralIDEAL pulse sequence utilizes the available magnetization more efficiently than the CSI
method. (2) In this work the use of spiral-IDEAL to map pH was validated by comparison of
pH mapped by this method to pH measured using conventional single-voxel CSI (5) and a
standard pH meter. In vitro application using hyperpolarized

13

C-bicarbonate was also

validated with a standard pH meter. Although the method itself is feasible, limited

13

C-

bicarbonate polarization and concentration prevented us from implementing the technique in
vivo.
The recipe of dissolving 13C-bicarbonate in glycerol inherently suffers from a low solubility
(1.7 M). (6) In addition, the amount of 13C-sodium bicarbonate dissolved in glycerol that can
be polarized efficiently in the DNP system was limited to 170 ul. Furthermore, the absolute
polarization for 13C-bicarbonate available at the 3T after the dissolution was measured at 24%. Lastly, the T1 relaxation time for

13

C-bicarbonate is ~30 s in vitro reduces to ~10 s in

vivo. A combination of the above mentioned factors restricted the in vivo implementation of
this technique.
An absolute polarization of 2-4% at the 3T for

13

C-bicarbonate resulted in an insufficient

SNR of 13C-carbon dioxide. As discussed in Chapter 4, based on the in vitro pH map using
hyperpolarized

13

C-bicarbonate with spiral-IDEAL, an increase in

13

C-carbon dioxide SNR

from ~2 to ~10 would yield an adequate in vivo pH map. This would require the polarization
of

13

C-bicarbonate to increase to 10-20% from 2-4%. In addition, other chemical

formulations with higher solubility (e.g.13C-cesium bicarbonate) could be used to ensure
higher injectable concentration to yield a better SNR in vivo. As well, newer DNP polarizer
technologies promising higher polarizations may allow for in vivo pH mapping using
hyperpolarized 13C-bicarbonate with spiral-IDEAL in future.
The spiral-IDEAL method described in Chapter 4 reads out the magnetization associated
with the FID first as well as three echoes to form the set of images of

13

C-bicarbonate and
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C-carbon dioxide images along with the Bo field correction. (2) Each echo is read out in a

single-shot spiral fashion after the excitation RF pulse. The spiral encoding is ensured by the
echo time shift from excitation to excitation. The flip angle for the excitation was chosen to
be 20 degrees such that it was adequate to form metabolite images while minimizing the
SNR variation from echo to echo. Minimal SNR variation across three echoes in each data
set ensured proper reconstruction to formulate the metabolite images. The choice of a smaller
TR also helped minimize the T1 relaxation effect in the final images. A variable flip angle
(VFA) scheme could be implemented to ensure uniform SNR across all echoes in future.

5.4 Future Work
The central questions about the mechanism of RILI motivated quantitation of metabolic
changes associated with RP, specifically hypoxic tissue environment, inflammation and
macrophage proliferation in this thesis. However, further work is needed in order to delineate
the interplay of these mechanistic processes and this will likely be aided by the use of animal
models of RILI. Quantification of the metabolic signature during RP based on changing total
dose, dose rate and fractionation scheme could be studied. The data could be collected for a
longer time span (e.g. zero days to 20 weeks post irradiation procedure) to understand the
evolution of the underlying disease. This would include lac/pyr ratio and identification of the
type of proliferating macrophages. The hypothesis that part of the lac/pyr enhancement may
be a result of highly metabolic infiltrating macrophages could also be tested. Overlay of
lac/pyr data over a) the hypoxia map from histology, and b) the macrophage map from
histology and comparison of the two data sets would help decode the origin of lac/pyr
changes in RP. Additional studies could be performed to profile the inflammatory cytokines,
type II pneumocytes endothelial cells and fibroblasts in a similar manner to test the
relationship between lac/pyr and the evolution of these physiological parameters. A study
could also be performed to evaluate the metabolic signature following administration of
radioprotector chemical species such as Superoxide Dismutase post-irradiation. (1)
Establishment of the mechanistic nature of the injury in more controlled animal models
would result in a better understanding of RP. A deeper level of understanding would benefit
the clinical studies, where the injury often progresses in a more complex manner than in the
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animal models due to other confounding factors. Some of these confounding factors include
the risk factors listed in Table 1-1 under the patient category. Animal models of RILI with
low paO2 prior to radiation therapy along with a variable conformation of the radiation
therapy across the lung may help elucidate these clinical risk factors in a better manner.
Clinical use of hyperpolarized

13

C-pyruvate MRI for detection of RP could aid in real-time

monitoring of ongoing radiation therapy of breast cancer, lung cancer and other thoracic
cancers that may be susceptible to RILI. The information could be used as feedback for
modification of the radiation therapy (or chemotherapy) plan or to determine whether antiinflammatory drugs would help (e.g. corticosteroids). As every patient may have a slightly
different physiological make-up, 13C-pyruvate MRI could assist with personalized treatment
where the metabolism of each patient could be recorded and used in the ongoing therapeutic
intervention. The non-ionizing nature of MRI also permits repeated scans for continuous
monitoring of a patient, which may not be possible with X-ray based modalities such as PET
and CT. Continuous monitoring may be important to track the evolution of both the tumour
response and the RP in cancer patients. Cancer cells may begin to demonstrate lower lac/pyr
post therapeutic intervention, as demonstrated in the literature with other cancer cell lines, (7)
while onset of RP leads to higher lac/pyr post radiation therapy, as demonstrated in this
thesis. In addition, hyperpolarized 13C-bicarbonate could be used in the clinic to map pH of
tumours undergoing radiation therapy, as pH plays a vital role in tumour progression and
therapy. (8) Successful phase I clinical trials for the use of hyperpolarized

13

C-substrates in

detection of prostate cancer (9) may pave the way for use of this exciting technique in a
variety of human diseases, including as RP, in the near future.

108

5.5 References
1.

Calveley VL, Khan MA, Yeung IW, et al. Partial volume rat lung irradiation:
temporal fluctuations of in-field and out-of-field DNA damage and inflammatory
cytokines following irradiation. International journal of radiation biology
2005;81:887-899.

2.

Wiesinger F, Weidl E, Menzel MI, et al. IDEAL spiral CSI for dynamic metabolic
MR imaging of hyperpolarized [1-13C]pyruvate. Magnetic Resonance in Medicine
2012;68:8-16.

3.

Hill R. Response of mouse lung to irradiation at different dose-rates. International
Journal of Radiation Oncology Biology Physics 1983;9:1043-1047.

4.

Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. New
England Journal of Medicine 1998;338:26-34.

5.

Gallagher FA, Kettunen MI, Day SE, et al. Magnetic resonance imaging of pH in
vivo using hyperpolarized 13C-labelled bicarbonate. Nature 2008;453:940-943.

6.

Wilson DM, Keshari KR, Larson PEZ, et al. Multi-compound polarization by DNP
allows simultaneous assessment of multiple enzymatic activities in vivo. Journal of
magnetic resonance 2010;205:141-147.

7.

Mason RP. Transmembrane pH gradients in vivo: measurements using fluorinated
vitamin B6 derivatives. Current medicinal chemistry 1999;6:481-500.

8.

Gillies RJ, Raghunand N, Karczmar GS, et al. MRI of the tumor microenvironment.
Journal of Magnetic Resonance Imaging 2002;16:430-450.

9.

Nelson SJ, Vigneron DB, Larson PE, et al. Metabolic imaging of patients with
prostate cancer using hyperpolarized [1-13C]pyruvate. Sci Transl Med 2013;5:198.
	
  

	
  

109

Appendix A-1: 13C-SNR enhancement using the
Transmit-Only/Receive-Only (TORO) RF coil
configuration
Chapter 2 used a switch-tuned

13

C-1H-birdcage RF coil that could be rapidly switched

between anatomical imaging mode (1H) and metabolic imaging mode (13C) by use of a PNjunction with isolation region diodes. This coil was designed and constructed by Heeseung
Lim. In addition, the fast switching mechanism was exploited to operate the birdcage coil as
a

13

C-transmit-only coil with a

13

C-surface coil for reception of the

13

C-signal, otherwise

known as the Transmit-only/Receive-only (TORO) configuration. The surface coil and the
fast switching mechanism between the birdcage coil and the surface coil were designed and
constructed by Kundan Thind. Overall, the combined system is capable of TORO operation
for 13C-imaging and spectroscopy and ordinary transmit/receive operation as a 1H coil, which
results in an enhanced 13C-SNR.
During the transmit phase of the TORO operation, the transmit coil must be tuned to the
resonant frequency while the receive coil is de-tuned and during the receive phase of the
TORO operation, the alternate is true. This rapid switching was accomplished by the
application of a direct current bias to the diodes in the RF hardware circuit. The bias current
tuned the 13C-1H birdcage transmit coil to resonate at the 13C-frequency while simultaneously
de-tuned the 13C-surface receive coil. The bias current required for the TORO operation was
provided by the MRI system but was not sufficient to bias all the diodes. For a fully
functioning TORO operation, the bias current was amplified using an additional fast
switching circuit and an external power supply in order to bias all the diodes. The complete
circuit diagram is shown in Figure A-1. During the transmit phase, the transmit RF pulse
from the scanner (consisting of both an alternating current component at the resonant
frequency and a direct current component) was filtered using a tank circuit to remove the
alternating current component. This yielded a clean direct current bias that was amplified
using a metal oxide semiconductor field effect transistor circuit and an Agilent U8002A
power supply. The amplified bias was then used to drive the

13

C-1H-birdcage transmit coil

and the 13C-surface receive coil. The orientation of the diodes on the coils was arranged such
that with the onset of the transmit pulse (the direct current bias being in the ‘ON’ state) the
birdcage transmit coil was tuned to the 13C-resonant frequency and the 13C-surface coil was
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de-tuned. After the transmit RF pulse, the direct current bias would switch to the ‘OFF’ state
which de-tuned the 13C-birdcage coil (it would switch to 1H frequency) and re-tuned the 13Csurface coil for signal reception.

Figure A-1: Detailed outline of the TORO operation. A tank circuit filters the alternating
current component from the transmit pulse. The resulting direct current bias was amplified
using a metal oxide semiconductor field effect transistor circuit and an Agilent U8002A
power supply. The amplified direct current bias was supplied to the 1H-13C-birdcage coil and
the 13C-surface coil that led to a tuned 1H-13C-birdcage coil (at 13C-resonant frequency for
efficient transmit) and a de-tuned 13C-surface receive coil. After the transmit pulse, the 1H13
C-birdcage coil was de-tuned (switches back to 1H-resonant frequency) and 13C-surface coil
was re-tuned to 13C-resonant frequency for efficient reception. Figure courtesy of Heeseung
Lim.
The SNR enhancement was calculated for the TORO operation over the regular
transmit/receive with the birdcage

13

C-1H-birdcage coil using a thermally-polarized

13

C-
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sodium acetate phantom. 2D 1H images were acquired for localization purposes in the
coronal plane with a 128 mm × 128 mm FOV and 40 mm slice thickness that resulted in an
in-plane resolution of 0.5 mm/voxel. A fast gradient echo sequence was employed with the
following parameters: TR = 34 ms, TE = 4.1 ms, flip angle = 90 degree and 16 averages. For
13

C-imaging, the in-plane resolution was reduced to 1.0 mm/voxel over the same FOV and

with the same slice thickness as the coronal 1H images. Images of the phantoms were
acquired using a broad-banded fast gradient echo sequence with TR = 34 ms, TE = 2.3 ms,
flip angle = 90 degree and 64 averages. Figure A-2 shows the 13C-images acquired from the
transmit/receive operation of the

13

C-1H-birdcage coil and the TORO setup. The

13

C-SNR

was computed to be 4.2 times higher in the TORO operation than the transmit/receive
operation of the 13C-1H-birdcage coil.

Figure A-2: 13C-2D-coronal image acquired using transmit/receive operation of the 13C-1Hbirdcage coil is shown on the left and a similar image acquired using the TORO operation
(with identical sequence parameters) is shown on the right. The TORO operation
demonstrates an SNR improvement by a factor of 4.2 times compared to the transmit/receive
configuration using the 13C-1H-birdcage coil. Figure courtesy of Heeseung Lim.
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Appendix A-2: Statistical tests used in the thesis
A brief introduction of the paired t-tests and mixed analysis of variance used in this thesis is
given below. The interested reader is referred to (1) for detailed reading.
Chapter 2 and 3 used paired two tailed t-tests to verify the significant differences between the
healthy and irradiated cohorts. The significance differences are verified using the p value
with a value of less than 0.05 generally considered as significant. The test assumes that the
samples follow a normal distribution, are independently collected and identically distributed.
The paired test consists of samples that are matched in pairs of similar units of measurement.
For the thesis, the samples from healthy and irradiated cohorts were paired with
administration of irradiation being the only difference between the two cohorts. Two tailed ttests are less sensitive to directional change compared to one tailed t-tests. Thus verification
of directional change by two tailed t-tests instead of one tailed t-tests ensured further
validation of the change between healthy and irradiated cohorts.
Mixed analysis of variance was performed in Chapter 3 to test for significant differences
between irradiated cohorts over time. In mixed analysis of variance, the difference between
two independent cohorts is tested while subjecting the cohorts to repeated measures. The two
factors include one that varies between-subjects and the other that varies within-subjects. The
test assumes that the samples follow a normal distribution, are independently collected and
are identically distributed. Adjustments could be made if any of these assumptions are
violated prior to the test.
Some of the cohorts tested may not have met all the assumptions required for the two tailed
paired t-tests and mixed analysis of variance due to the small number of samples. Increasing
the sample size should ensure validity of the assumptions or corrections required for the
assumptions before testing for the significant differences between cohorts.
(1)

Steel RG, Torrie JH and Dickey DA. Principles and Procedures of Statistics: A
Biometrical Approach. McGraw-Hill; 1996
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Use of IDEAL technique with Hyperpolarized 13C-bicarbonate to map pH.
Kundan Thind*, Alexei Ouriadov, Albert Chen, Heeseung Lim, Curtis Wiens, Francisco
Martinez, Charles McKenzie, Timothy Scholl, Giles Santyr.
Imaging Network of Ontario, January 2013.
Monitoring Therapeutic Response in a Rat Model of Glioblastoma Multiforme with
Hyperpolarized [1-13C] Pyruvate. Heeseung Lim, Kundan Thind, Timothy Yeung, Francisco
Martinez, Timothy J. Scholl.
Imaging Network of Ontario, January 2013.
A Transmit-Only/Receive-Only Radiofrequency Coil Configuration for Hyperpolarized
129
Xe Magnetic Resonance Imaging. Ozkan Doganay, Kundan Thind, Trevor Wade, Alexei
Ouriadov, Giles Santyr.
The Third International Workshop on Metabolic Imaging, July 2012.
Quantification of pH in the rat thorax using hyperpolarized 13C-bicarbonate.
Kundan Thind*, Francisco Martinez, Albert Chen, Alexei Ouriadov, Timothy Scholl and
Giles Santyr.
American Thoracic Society, May 2012.
Detection of Radiation-Induced Lung Injury using Hyperpolarized 13C Magnetic Resonance
Spectroscopy and Imaging. Kundan Thind*, Albert Chen, Alexei V. Ouriadov, Lanette
Friesen-Waldner, Matthew Fox, Eugene Wong, Giles Santyr.
The International Society of Magnetic Resonance in Medicine, May 2012.
Switch-Tuned Dual-Frequency Birdcage RF Coil for 13C and 1H Imaging. Heeseung Lim,
Kundan Thind, Jian-xiong Wang, Andrew Alejski, Francisco Martinez, and Timothy Scholl.
Cancer Care Ontario, April 2010.
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Hyperpolarized 13C Magnetic Resonance Imaging and Dynamic Spectroscopy for Detection
of Radiation-Induced Lung Injury. Kundan Thind*, Alexei V. Ouriadov, Lanette FriesenWaldner, Matthew Fox, Eugene Wong, Giles Santyr.
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McMaster University
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September 2006 – April 2007, Senate scholarship
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May 2008 – April 2009, Treasurer, Engineer World Health, McMaster Chapter, McMaster
University, Hamilton
. Managed allocation of financial resources
. Organized and helped in fundraising events
September 2006 – November 2008, Captain, Outdoor Soccer team, Intramural sports,
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